
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A5A48AF2307305A5A40035C8EDCF.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="renfail">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372509/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Renal Failure">
<meta name="citation_title" content="Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines">
<meta name="citation_author" content="Yushan Sun">
<meta name="citation_author_institution" content="First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China">
<meta name="citation_author" content="Guanghui Pan">
<meta name="citation_author_institution" content="Affiliated Hospital of Shandong, University of Traditional Chinese Medicine, Jinan, China">
<meta name="citation_author" content="Chunxing Wang">
<meta name="citation_author_institution" content="First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China">
<meta name="citation_author" content="Zhenwei Xiao">
<meta name="citation_author_institution" content="Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="47">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="2538798">
<meta name="citation_doi" content="10.1080/0886022X.2025.2538798">
<meta name="citation_pmid" content="40841164">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372509/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372509/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372509/pdf/IRNF_47_2538798.pdf">
<meta name="description" content="Chronic kidney disease (CKD) is characterized by a progressive decline of renal function, leading to multisystem problems and finally culminating in end-stage renal disease (ESRD). It has progressively emerged as a major global health issue. The ...">
<meta name="og:title" content="Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Chronic kidney disease (CKD) is characterized by a progressive decline of renal function, leading to multisystem problems and finally culminating in end-stage renal disease (ESRD). It has progressively emerged as a major global health issue. The ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372509/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372509">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1080/0886022X.2025.2538798"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/IRNF_47_2538798.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372509%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372509/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372509/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372509/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-renfail.png" alt="Renal Failure logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Renal Failure" title="Link to Renal Failure" shape="default" href="https://doi.org/10.1080/0886022X.2025.2538798" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Ren Fail</button></div>. 2025 Aug 21;47(1):2538798. doi: <a href="https://doi.org/10.1080/0886022X.2025.2538798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1080/0886022X.2025.2538798</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Ren%20Fail%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ren%20Fail%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Ren%20Fail%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Ren%20Fail%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yushan Sun</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yushan Sun</span></h3>
<div class="p">
<sup><sup>a</sup></sup>First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China</div>
<div>Conceptualization, Methodology, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yushan Sun</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Guanghui Pan</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Guanghui Pan</span></h3>
<div class="p">
<sup><sup>b</sup></sup>Affiliated Hospital of Shandong, University of Traditional Chinese Medicine, Jinan, China</div>
<div>Conceptualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guanghui Pan</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chunxing Wang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chunxing Wang</span></h3>
<div class="p">
<sup><sup>a</sup></sup>First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chunxing Wang</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiao%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Zhenwei Xiao</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Zhenwei Xiao</span></h3>
<div class="p">
<sup><sup>c</sup></sup>Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China</div>
<div>Funding acquisition, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiao%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhenwei Xiao</span></a>
</div>
</div>
<sup>c,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="AF0001">
<sup><sup>a</sup></sup>First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China</div>
<div id="AF0002">
<sup><sup>b</sup></sup>Affiliated Hospital of Shandong, University of Traditional Chinese Medicine, Jinan, China</div>
<div id="AF0003">
<sup><sup>c</sup></sup>Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China</div>
<div class="author-notes p"><div class="fn" id="AN0001">
<sup>✉</sup><p class="display-inline">CONTACT Zhenwei Xiao <span>xiaozw2006@126.com</span>
Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.</p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Yushan Sun</span></strong>: <span class="role">Conceptualization, Methodology, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Guanghui Pan</span></strong>: <span class="role">Conceptualization, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Chunxing Wang</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Zhenwei Xiao</span></strong>: <span class="role">Funding acquisition, Supervision, Writing – review &amp; editing</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 17; Accepted 2025 Jul 6; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</div>
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372509  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841164/" class="usa-link">40841164</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Chronic kidney disease (CKD) is characterized by a progressive decline of renal function, leading to multisystem problems and finally culminating in end-stage renal disease (ESRD). It has progressively emerged as a major global health issue. The nucleotide-binding oligomerization domain-like receptor pyrin domain-containing 3 (NLRP3) inflammasome contributes to the inflammatory response chiefly by facilitating the secretion of inflammatory mediators, including interleukin-1β and interleukin-18. Recent studies have underscored the significance of NLRP3 inflammasome in renal pathology that is associated with CKD. In addition, a large number of studies have shown that traditional Chinese medicines (TCMS) can regulate NLRP3 through multiple targets and pathways, demonstrating significant potential in the treatment of CKD. These natural products offer advantages such as low costs and minimal side effects, making them a viable supplement or alternative to traditional treatment approaches for CKD. A literature review approach was employed to systematically search databases including Web of Science, ScienceDirect, and PubMed. Search keywords comprised ‘Chronic kidney disease’, ‘NLRP3 inflammasome’, ‘traditional Chinese medicine’, and their relevant synonyms/combinations. Through reviewing abstracts and full texts, the relationships between CKD and NLRP3 inflammasome, as well as the pharmacological mechanisms of TCMS, were classified and summarized. This study also explores the therapeutic potential of TCMS in regulating NLRP3 inflammasome. These findings might offer prospective diagnostic and therapeutic approaches for targeted or supplementary therapy of CKD.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Chronic kidney disease, NLRP3 inflammasome, mechanism, plant metabolites, traditional Chinese medicine</p></section></section><section id="S0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Chronic kidney disease (CKD) refers to a long-term, irreversible decline in renal function, characterized by the progressive loss of kidney function that can ultimately lead to renal failure [<a href="#CIT0001" class="usa-link" aria-describedby="CIT0001">1</a>]. CKD has emerged as a critical global health challenge, ranking among the leading threats alongside cardiovascular diseases, diabetes, and cancer, due to its high prevalence, low awareness, complex complications, poor prognosis, and substantial medical costs. The global median prevalence of CKD is 9.5%, and with the aging population and rising incidence of conditions like diabetes and hypertension, its prevalence continues to increase [<a href="#CIT0002" class="usa-link" aria-describedby="CIT0002">2–4</a>].</p>
<p>Current management of CKD primarily comprises three stages: early drug therapy, dialysis, and kidney transplantation. Early pharmacotherapy plays a pivotal role in delaying CKD progression, including interventions with renin-angiotensin system blockers and sodium-glucose cotransporter 2 inhibitors. Treatment also involves managing complications such as anemia and electrolyte disorders, as well as nutritional support through essential amino acid supplementation to maintain overall patient health [<a href="#CIT0003" class="usa-link" aria-describedby="CIT0003">3</a>]. However, despite the efficacy of existing therapies in symptom management, the high morbidity and mortality associated with CKD remain a significant concern, making precise targeted treatment a focal point of current research.</p>
<p>The nucleotide-binding oligomerization domain-like receptor pyrin domain-containin g 3 (NLRP3) inflammasome, a cytoplasmic cysteine-aspartic acid protease-activating complex first proposed by Martinon in 2002, participates in innate immune responses [<a href="#CIT0005" class="usa-link" aria-describedby="CIT0005">5</a>]. As the most widely studied inflammation to date, it responds to diverse stimuli and plays a central role in the pathogenesis of numerous inflammatory diseases. Research has highlighted the critical role of the NLRP3 inflammasome in multi-organ inflammatory disorders, making the study of its regulatory mechanisms essential for developing novel anti-inflammatory therapies. In the liver, it is associated with nonalcoholic steatohepatitis and viral hepatitis, where overactivation exacerbates inflammatory responses and hepatocyte damage, driving disease progression. In the heart, it is linked to atherosclerosis, myocardial infarction, and heart failure, promoting atherosclerotic plaque formation, increasing cardiovascular event risk, and worsening myocardial cell damage post-infarction, thereby impacting cardiac function recovery. In the brain, abnormal activation is associated with neurodegenerative diseases such as Alzheimer’s and Parkinson’s, inducing neuroinflammation and cell death that accelerate cognitive and motor decline [<a href="#CIT0006" class="usa-link" aria-describedby="CIT0006">6–8</a>].</p>
<p>In recent years, scientific evidence has established a close association between CKD and the NLRP3 inflammasome. Excessive NLRP3 inflammasome activation is considered a key factor contributing to renal tissue damage and dysfunction, playing a significant role in inducing renal inflammation and fibrosis [<a href="#CIT0009" class="usa-link" aria-describedby="CIT0009">9</a>]. Renal tissue from CKD patients, particularly in renal tubular epithelial cells (RTEC) and macrophages, exhibits a notable upregulation of NLRP3 inflammasome expression [<a href="#CIT0010" class="usa-link" aria-describedby="CIT0010">10</a>]. This expression increase is not only closely linked to local renal inflammatory responses but may also exacerbate kidney damage through complex mechanisms, including ion flux alterations, organelle damage, ferroptosis, autophagy dysregulation, and modulation of intestinal flora metabolism.</p>
<p>Currently, small-molecule inhibitors targeting NLRP3 inflammasome components are being explored as potential therapeutics for kidney-related diseases [<a href="#CIT0011" class="usa-link" aria-describedby="CIT0011">11</a>]. Moreover, numerous studies have indicated that traditional Chinese medicines (TCMS) can effectively modulate NLRP3 inflammasome activity through its multi-component, multi-pathway properties, thereby improving symptoms and prognosis in CKD patients [<a href="#CIT0012" class="usa-link" aria-describedby="CIT0012">12–14</a>]. This review aims to summarize the structure and function of the NLRP3 inflammasome, discuss its relationship with CKD, and outline how TCMS delays CKD progression by intervening in NLRP3 inflammasome activation, seeking to provide a comprehensive theoretical foundation and clinical perspective for CKD prevention and treatment.</p></section><section id="S0002"><h2 class="pmc_sec_title">2. Overview of the NLRP3 inflammasome</h2>
<p>The NLRP3 inflammasome primarily consists of three key proteins: the apoptosis-associated speck-like protein containing a CARD (ASC), the NLRP3 protein, and pro-cysteine aspartic acid-specific protease-1 (Pro-caspase-1) [<a href="#CIT0015" class="usa-link" aria-describedby="CIT0015">15</a>,<a href="#CIT0016" class="usa-link" aria-describedby="CIT0016">16</a>]. The CARD of ASC enables the recruitment of Pro-caspase-1. As an adaptor protein, ASC possesses two domains—the pyrin domain and caspase recruitment domain—which act as a ‘bridge’ to connect receptor and effector proteins, thereby forming an efficient signal transduction complex [<a href="#CIT0017" class="usa-link" aria-describedby="CIT0017">17</a>]. NLRP3 serves as the core component of the inflammation, comprising three major domains: the N-terminal pyrin domain (PYD), the C-terminal leucine-rich repeat (LRR) domain, and the centrally located NACHT domain (also referred to as the nucleotide-binding oligomerization domain). The PYD interacts with ASC <em>via</em> PYD-PYD binding, while the nucleotide-binding oligomerization domain primarily promotes self-oligomerization. The LRR domain is predominantly responsible for stimulus recognition [<a href="#CIT0018" class="usa-link" aria-describedby="CIT0018">18</a>].</p></section><section id="S0003"><h2 class="pmc_sec_title">3. Activation pathway of the NLRP3 inflammasome</h2>
<p>The NLRP3 inflammasome activates in response to diverse pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Its primary function is to activate caspase-1, which in turn induces the maturation and secretion of pro-inflammatory cytokines interleukin-1β (IL-1β) and interleukin-18 (IL-18). Caspase-1 also cleaves the membrane perforin gasdermin D (GSDMD), leading to cell lysis and release of inflammatory mediators [<a href="#CIT0016" class="usa-link" aria-describedby="CIT0016">16</a>,<a href="#CIT0019" class="usa-link" aria-describedby="CIT0019">19</a>]. NLRP3 inflammasome activation occurs in two distinct phases: ‘priming’ and ‘activation’ [<a href="#CIT0006" class="usa-link" aria-describedby="CIT0006">6</a>,<a href="#CIT0020" class="usa-link" aria-describedby="CIT0020">20–22</a>].</p>
<p>The priming phase is initiated by pattern recognition receptor-mediated signaling, including tumor necrosis factor-α (TNF-α) and toll-like receptor (TLR4) signaling. This signaling activates inflammatory vesicle components such as NLRP3, IL-1β, and IL-18 through modulation of the nuclear factor-kappa B (NF-κB) signaling pathway and other transcriptional processes [<a href="#CIT0022" class="usa-link" aria-describedby="CIT0022">22–24</a>]. Activation signals are triggered by PAMPs and DAMPs, including pore-forming toxins, ATP, RNA viruses, urate crystals, ion flux disturbances, reactive oxygen species (ROS) production, mitochondrial dysfunction, and lysosomal damage [<a href="#CIT0023" class="usa-link" aria-describedby="CIT0023">23</a>,<a href="#CIT0025" class="usa-link" aria-describedby="CIT0025">25</a>]. During the activation of NLRP3 inflammasome, the NACHT domain of NLRP3 binds to LRRs, maintaining a state of self-inhibition. When PAMPs and DAMPs appear, NLRP3 releases its self-inhibition state, exposes the NACHT domain, and oligomerizes. NLRP3 then undergoes auto-oligomerization to form an open octameric structure. Interactions between NACHT domains of NLRP3 initiate oligomerization, after which its PYD interacts with the PYD of ASC, promoting ASC oligomerization. The oligomerized ASC further assembles into helical filamentous structures and eventually forms large aggregates called ‘ASC specks’ [<a href="#CIT0026" class="usa-link" aria-describedby="CIT0026">26</a>]. Under normal conditions, NLRP3 and ASC are diffusely distributed in the cytoplasm. Upon NLRP3 activation, both proteins rapidly migrate and form punctate structures around the nucleus—the ASC specks [<a href="#CIT0027" class="usa-link" aria-describedby="CIT0027">27</a>]. Knockdown of endogenous ASC expression or inhibition of ASC oligomerization significantly suppresses NLRP3. Pro-casepase-1 is recruited into the inflammation complex through the interaction between its CARD and the CARD of ASC, subsequently undergoing autocatalysis to cleave itself into active caspase-1. Once the components of the inflammation assemble into an active complex, caspase-1 is activated. This activation initiates the secretion of downstream mature pro-inflammatory cytokines, such as IL-1β and IL-18 [<a href="#CIT0028" class="usa-link" aria-describedby="CIT0028">28</a>]. Simultaneously, activated caspase-1 can also cleave the key pro-inflammatory protein GSDMD to C-GSDMD and N-GSDMD [<a href="#CIT0029" class="usa-link" aria-describedby="CIT0029">29</a>,<a href="#CIT0030" class="usa-link" aria-describedby="CIT0030">30</a>]. After N-GADMD is activated and released, pores are formed on the membrane through cell membrane lipid interactions, resulting in the release of IL-1β and IL-18 to the outside of the cell and inducing pyroptosis [<a href="#CIT0019" class="usa-link" aria-describedby="CIT0019">19</a>]. IL-1β and IL-18 can not only recruit and activate immune cells to aggravate the inflammatory response, but also may affect RTEC through autocrine or paracrine pathways, aggravating the pathological process of renal tubular injury and fibrosis by influencing their proliferation and apoptosis [<a href="#CIT0031" class="usa-link" aria-describedby="CIT0031">31</a>].</p>
<p>However, beyond the classical pathways, there are non-classical activation pathways for the NLRP3 inflammasome. When dangerous signals such as lipopolysaccharide (LPS) are detected in the cytoplasm, caspase-11 (in mice) or caspase-4/5 (in humans) are activated, which is considered to be the starting point of non-classical pathways [<a href="#CIT0032" class="usa-link" aria-describedby="CIT0032">32</a>,<a href="#CIT0033" class="usa-link" aria-describedby="CIT0033">33</a>]. Recent studies have found that Nur77 can function as an intracellular LPS sensor, binding to mitochondrial DNA and LPS to activate the non-classical NLRP3 inflammasome pathway, thereby regulating the body’s immune response [<a href="#CIT0034" class="usa-link" aria-describedby="CIT0034">34</a>,<a href="#CIT0035" class="usa-link" aria-describedby="CIT0035">35</a>].</p>
<p>Additionally, while NLRP3 typically functions as part of the inflammation complex, it also possesses some independent functions. More and more studies have revealed that the NLRP3 protein can participate in the pathogenesis of diseases independently of the inflammation NLRP3-ASC-caspase-1-IL-1β-IL-18 signal axis. NLRP3 can also form a complex with ASC and caspase-8 in mitochondria, thereby regulating the apoptosis of renal and intestinal epithelial cells [<a href="#CIT0036" class="usa-link" aria-describedby="CIT0036">36</a>,<a href="#CIT0037" class="usa-link" aria-describedby="CIT0037">37</a>]. Other research has shown that the Z-DNA binding protein 1-NLRP3 inflammasome can be specifically activated by viral RNA products or endogenous nucleic acid ligands, which have been shown to promote a mixed form of cell death-pan-apoptosis (<a href="#F0001" class="usa-link">Figure 1</a>) [<a href="#CIT0038" class="usa-link" aria-describedby="CIT0038">38</a>].</p>
<figure class="fig xbox font-sm" id="F0001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372509_IRNF_A_2538798_F0001_C.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b0/12372509/16394e93f734/IRNF_A_2538798_F0001_C.jpg" loading="lazy" height="495" width="750" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Classical signaling pathway of the NLRP3 inflammasome [20].</p>
<p>TNF-α: Tumor Necrosis Factor-α;TLR4: Toll-like Receptor 4; NF-κB: Nuclear Factor-Kappa B; NACHT: NAIP, CIITA, HET-E, TP1 domain; PYD: Pyrin Domain; ASC: Apoptosis-associated Speck-like Protein containing a CARD; NLRP3: Nucleotide-binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3; LRR: Leucine-rich Repeat; Pro-caspase-1: Pro-cysteine aspartic acid protease-1; Pro-IL-1β: Pro-Interleukin-1β; Pro-IL-18: Pro-Interleukin-18; IL-1β: Interleukin-1β; IL-18: Interleukin-18; GSDMD: Gasdermin D; N-GSDMD: N-terminal fragment of Gasdermin D.</p>
<p>(Created in <a href="https://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com</a>)</p></figcaption></figure></section><section id="S0004"><h2 class="pmc_sec_title">4. Mechanisms of NLRP3 inflammasome</h2>
<p>Activation of the NLRP3 inflammasome entails multiple molecular and cellular events, along with dysregulations in internal environmental homeostasis. These include ion flux alterations, organelle damage, pyroptosis, ferroptosis, autophagy, and metabolic modulation of the intestinal microbiota [<a href="#CIT0039" class="usa-link" aria-describedby="CIT0039">39–44</a>]. Additionally, while NLRP3 proteins are involved in assembling NLRP3 inflammasomes to execute their functions, they can also influence the pathophysiology of CKD independently of inflammation complexes (<a href="#F0002" class="usa-link">Figure 2</a>).</p>
<figure class="fig xbox font-sm" id="F0002"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372509_IRNF_A_2538798_F0002_C.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b0/12372509/b2fb2a5b4b26/IRNF_A_2538798_F0002_C.jpg" loading="lazy" height="527" width="750" alt="Figure 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/F0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mechanisms of the NLRP3 inflammasome activation [<a href="#CIT0039" class="usa-link" aria-describedby="CIT0039">39</a>,<a href="#CIT0040" class="usa-link" aria-describedby="CIT0040">40</a>].</p>
<p>NADPH: Nicotinamide Adenine Dinucleotide Phosphate; ERS: Endoplasmic Reticulum Stress; ROS: ROS; mtDNA: Mitochondrial DNA; mtRNA: Mitochondrial RNA; TXNIP: Thioredoxin-interacting Protein; NEK7: NIMA-related Kinase 7; LPS: Lipopolysaccharide; SCFAs: Short-Chain Fatty Acids; ASC: Apoptosis-associated Speck-like Protein containing a CARD; Pro-Caspase-1: Pro-cysteine-aspartic acid Protease-1; NLRP3: Nucleotide-binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3.</p>
<p>(Created in <a href="https://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com</a>)</p></figcaption></figure><section id="S0004-S2001"><h3 class="pmc_sec_title">4.1. Ion flux</h3>
<section id="S0004-S2001-S3001"><h4 class="pmc_sec_title">4.1.1. Potassium ions</h4>
<p>Potassium ion (K<sup>+</sup>) efflux is recognized as a key upstream event in NLRP3 inflammasome activation [<a href="#CIT0045" class="usa-link" aria-describedby="CIT0045">45</a>,<a href="#CIT0046" class="usa-link" aria-describedby="CIT0046">46</a>]. In pathological states (e.g., infection, tissue injury), increased extracellular K<sup>+</sup> concentrations act as danger signals, triggering activation of the NLRP3 inflammatory complex. Notably, NLRP3 inflammasome activation can occur even in the absence of activators by removing K<sup>+</sup> from cell culture media, highlighting the potential significance of K<sup>+</sup> in NLRP3 inflammasome signaling.</p>
<p>The role of NLRP3 as a sensor for intracellular K<sup>+</sup> efflux has been confirmed. NIMA-associated kinase 7 (<em>NEK7</em>), a protein that binds to NLRP3, has emerged as a critical player in the K<sup>+</sup> efflux downstream pathway. During K<sup>+</sup> efflux, <em>NEK7</em> interacts with the LRR domain of NLRP3, promoting its structural rearrangement and oligomerization, which in turn triggers inflammation activation [<a href="#CIT0047" class="usa-link" aria-describedby="CIT0047">47–49</a>]. Most studies have focused on the role of NLRP3 protein and K<sup>+</sup> in inflammation activation. However, there is currently no direct evidence to show that K<sup>+</sup> can interact directly with the NLRP3 protein. Another study has shown that a reduction in intracellular K<sup>+</sup> levels not only triggers the NLRP3 response but also induces structural changes in ASC oligomers and enhances the recruitment of the Pro-caspase-1 to ASC specks, a process that is independent of NLRP3 [<a href="#CIT0050" class="usa-link" aria-describedby="CIT0050">50</a>]. This implies that the role of K<sup>+</sup> in the activation of inflammations may be multidimensional. In addition, the activation of NLRP3 inflammasome triggered by certain small molecule compounds, such as imiquimod and chlorfenuron, seems to be independent of K<sup>+</sup> outflow but relies on the production of mitochondrial reactive oxygen species (mtROS), indicating that K<sup>+</sup> outflow may not be an essential prerequisite for the activation of NLRP3 inflammasome [<a href="#CIT0051" class="usa-link" aria-describedby="CIT0051">51</a>,<a href="#CIT0052" class="usa-link" aria-describedby="CIT0052">52</a>].</p>
<p>Despite a lack of direct studies to definitively clarify the direct interaction of potassium ions with the NLRP3 inflammasome in CKD, it is possible that K<sup>+</sup> may be indirectly implicated in the inflammatory response and pathological process of CKD by influencing NLRP3 activation.</p></section><section id="S0004-S2001-S3002"><h4 class="pmc_sec_title">4.1.2. Calcium ions</h4>
<p>Elevated cytosolic calcium (Ca<sup>2+</sup>) is frequently required for NLRP3 inflammasome activation. Various NLRP3 inflammasome agonists, including cytoplasmic Ca<sup>2+</sup> influx and ROS, can activate intracellular Ca<sup>2+</sup> signaling cascades <em>via</em> calcium receptor (CASR) interaction with phospholipase C, consequently influencing NLRP3 [<a href="#CIT0053" class="usa-link" aria-describedby="CIT0053">53–55</a>].</p>
<p>Researchers have found that lipopolysaccharide and palmitic acid decrease lysosomal Ca<sup>2+</sup> levels while increasing cytoplasmic Ca<sup>2+</sup>
<em>via</em> ROS, triggering NLRP3 inflammasome activation. Blocking Ca<sup>2+</sup> channels in the cell membrane can prevent caspase-1 activation and IL-1β production [<a href="#CIT0056" class="usa-link" aria-describedby="CIT0056">56</a>], suggesting that Ca<sup>2+</sup> may act on inflammation downstream components. Pharmacological studies showed that inhibiting large-conductance calcium-activated potassium channels suppress silica-induced lysosomal membrane damage and NLRP3 inflammasome activation [<a href="#CIT0057" class="usa-link" aria-describedby="CIT0057">57</a>]. However, the mechanism by which intracellular Ca<sup>2+</sup> elevation promotes NLRP3 activation remains unclear. Notably, K<sup>+</sup> efflux typically occurs concurrently with Ca<sup>2+</sup> influx during NLRP3 inflammasome activation [<a href="#CIT0058" class="usa-link" aria-describedby="CIT0058">58</a>]. A cell experiment demonstrated that when directly triggering rapid cytoplasmic K<sup>+</sup> efflux, extracellular Ca<sup>2+</sup> influx and cytoplasmic Ca<sup>2+</sup> elevation are not essential signals for NLRP3 inflammasome activation [<a href="#CIT0059" class="usa-link" aria-describedby="CIT0059">59</a>]. Thus, Ca<sup>2+</sup> flux may serve as a regulator—rather than an absolute requirement—for NLRP3 inflammasome activation.</p></section><section id="S0004-S2001-S3003"><h4 class="pmc_sec_title">4.1.3. Other ions</h4>
<p>As existing research deepens, increasing evidence indicates that ion fluxes such as Na<sup>+</sup>, Cl<sup>−</sup>, Fe<sup>2+</sup>, Zn<sup>2+</sup>, and Mn<sup>2+</sup> also play a significant role in the assembly of the NLRP3 inflammasome [<a href="#CIT0039" class="usa-link" aria-describedby="CIT0039">39</a>,<a href="#CIT0060" class="usa-link" aria-describedby="CIT0060">60–63</a>]. However, currently, these ions appear to act synergistically with K<sup>+</sup> and cannot independently activate the NLRP3 inflammasome. In the future, more studies are needed on the potential ionic mechanisms.</p></section></section><section id="S0004-S2002"><h3 class="pmc_sec_title">4.2. Organelle damage</h3>
<section id="S0004-S2002-S3001"><h4 class="pmc_sec_title">4.2.1. Mitochondrial damage</h4>
<p>Due to the kidney’s unique high oxygen consumption characteristics, the mitochondria in its cells are not only abundant but also exhibit high adaptability and repair capabilities. However, persistent mitochondrial damage and excessive activation of inflammations can induce inflammatory responses and tissue damage [<a href="#CIT0064" class="usa-link" aria-describedby="CIT0064">64</a>,<a href="#CIT0065" class="usa-link" aria-describedby="CIT0065">65</a>]. There is a potential interaction mechanism between mitochondrial damage and the activation of the NLRP3 inflammasome [<a href="#CIT0066" class="usa-link" aria-describedby="CIT0066">66</a>,<a href="#CIT0067" class="usa-link" aria-describedby="CIT0067">67</a>]. In transforming growth factor-β-treated (TGF-β) RTEC and animal models of renal injury, researchers have found that peroxisome proliferator - activated receptor - gamma coactivator 1-α (PGC-1α) can inhibit the activation of the NLRP3 inflammasome pathway by reducing mitochondrial damage and restoring mitochondrial integrity, thereby reducing renal cell damage and fibrosis [<a href="#CIT0068" class="usa-link" aria-describedby="CIT0068">68</a>]. This reveals the importance of regulating mitochondrial activity and dynamics in modulating the NLRP3 inflammasome signaling pathway.</p>
<p>Damage to mitochondria results in dysfunction of the mitochondrial electron transport chain, leading to a significant increase in the generation of mtROS [<a href="#CIT0069" class="usa-link" aria-describedby="CIT0069">69</a>]. This process promotes the oligomerization of NLRP3—a crucial factor in the activation of the NLRP3 inflammasome. Thioredoxin-interacting protein (TXNIP) is an essential element of the thioredoxin system. It can significantly influence the body’s reaction to oxidative stress [<a href="#CIT0070" class="usa-link" aria-describedby="CIT0070">70–73</a>]. The overproduction of mtROS can impede the antioxidant activity of the endogenous antioxidant thioredoxin, leading to its dissociation from TXNIP. The separated TXNIP binds to the NLRP3 inflammasome and promotes the activation of the NLRP3 inflammasome, thereby exacerbating renal tubular injury and fibrosis. Knockout of the NLRP3 gene markedly diminishes inflammation activity indicators, improving kidney injury [<a href="#CIT0040" class="usa-link" aria-describedby="CIT0040">40</a>,<a href="#CIT0074" class="usa-link" aria-describedby="CIT0074">74–76</a>].</p>
<p>Furthermore, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, a key enzyme in the production of ROS, has been demonstrated to be closely associated with the activation of the NLRP3 inflammasome. NADPH oxidase can result in the overproduction of ROS [<a href="#CIT0077" class="usa-link" aria-describedby="CIT0077">77–80</a>]. In a mouse model of CKD, inhibiting the principal pathway of NADPH oxidase/ROS/NLRP3 inflammasome effectively diminishes the inflammatory response in the kidneys and reduces the extent of fibrosis [<a href="#CIT0081" class="usa-link" aria-describedby="CIT0081">81</a>]. The activation of mtROS also exacerbates the release and synthesis of oxidized mitochondrial DNA, mitochondrial RNA, and other mitochondrial-related proteins and lipids, which in turn further activate the NLRP3 inflammasome as DAMPs [<a href="#CIT0082" class="usa-link" aria-describedby="CIT0082">82</a>,<a href="#CIT0083" class="usa-link" aria-describedby="CIT0083">83</a>]. However, in contrast to the aforementioned perspective, recent innovative research by Billingham and his team has discovered that macrophages can still activate NLRP3 signaling in response to various NLRP3 agonists, even in the absence of mtROS [<a href="#CIT0069" class="usa-link" aria-describedby="CIT0069">69</a>]. This suggests that mtROS may not be essential for the activation of NLRP3.</p></section><section id="S0004-S2002-S3002"><h4 class="pmc_sec_title">4.2.2. Lysosomal damage</h4>
<p>The lysosome serves as the core degradation center within cells. Damage to lysosomes is frequently associated with various kidney diseases [<a href="#CIT0084" class="usa-link" aria-describedby="CIT0084">84</a>,<a href="#CIT0085" class="usa-link" aria-describedby="CIT0085">85</a>], and the NLRP3 inflammasome also plays a crucial role in this pathological process.</p>
<p>Alterations in lysosomal protease activity have been observed during renal pathology. Research indicates that lysosomal acidification-mediated cathepsin, such as cathepsin B, L, C, S, and X, are implicated in the activation of the NLRP3 inflammasome, particularly the release of lysosomal cathepsin B [<a href="#CIT0086" class="usa-link" aria-describedby="CIT0086">86–89</a>]. Mature cathepsin B facilitates the interaction between NLRP3 and ASC, and promotes ASC oligomerization to form plaques, which is crucial for NLRP3 activation. Zheng et al. demonstrated through <em>in vitro</em> and <em>in vivo</em> experiments that the activities of lysosomal cathepsins B, S, and L are increased in cells with activated NLRP3 inflammasomes. Treatment with flufenidone significantly downregulates cathepsin activity. Under inflammatory conditions induced by LPS/ATP stimulation or hypoxia/reoxygenation treatment, cathepsin B is released from lysosomes and co-localizes with NLRP3 in the cytoplasm. Flufenidone reduces NLRP3 inflammasome activation by inhibiting cathepsin B release [<a href="#CIT0090" class="usa-link" aria-describedby="CIT0090">90</a>]. Concurrently, leaked lysosomal cathepsin can directly impact mitochondria, causing mitochondrial damage and ROS production [<a href="#CIT0091" class="usa-link" aria-describedby="CIT0091">91</a>], and can induce NLRP3 inflammasome activation <em>via</em> the ROS/TXNIP/NLRP3 signaling pathway, suggesting that lysosomal damage may activate inflammations by disrupting mitochondrial function [<a href="#CIT0073" class="usa-link" aria-describedby="CIT0073">73</a>]. Further research has indicated that this process might be mediated by affecting the flow of calcium ions within lysosomes. Apilimod is a compound that disrupts normal lysosomal function. By compromising lysosomal integrity and altering the acidic environment within lysosomes, Apilimod triggers lysosome-associated signaling pathways to activate the NLRP3 inflammasome. Specifically, Apilimod activates the transient receptor potential mucolipin 1 calcium channel on lysosomes, prompting calcium release from lysosomes into the cytoplasm. Calcium overload subsequently disrupts mitochondrial membrane potential, increasing mtROS production, mtROS then oxidatively modify components of the NLRP3 inflammasome, ultimately leading to its activation [<a href="#CIT0092" class="usa-link" aria-describedby="CIT0092">92</a>]. On the contrary, calcium chelators and lysosomal calcium channel inhibitors can eliminate Apilimod-induced mitochondrial damage and NLRP3 inflammasome activation [<a href="#CIT0092" class="usa-link" aria-describedby="CIT0092">92</a>].</p></section><section id="S0004-S2002-S3003"><h4 class="pmc_sec_title">4.2.3. Endoplasmic reticulum stress</h4>
<p>The endoplasmic reticulum (ER) is a critical organelle tasked with protein synthesis, folding, and modification within cells. The buildup of unfolded or misfolded proteins in the ER can result in endoplasmic reticulum stress [<a href="#CIT0093" class="usa-link" aria-describedby="CIT0093">93</a>]. Multiple pathogenic causes, such as free fatty acids, angiotensin II, advanced glycation end products, and hyperglycemia, can trigger endoplasmic reticulum stress (ERS). These variables disturb the balance of the ER and ultimately result in the aggregation of misfolded proteins. The unfolded protein responses subsequently trigger the activation of the NLRP3 inflammasome [<a href="#CIT0041" class="usa-link" aria-describedby="CIT0041">41</a>,<a href="#CIT0094" class="usa-link" aria-describedby="CIT0094">94</a>].</p>
<p>During ERS, ROS not only act as signaling molecules to modulate mitochondrial function and cellular redox status but also promote the interaction and activation of NLRP3 inflammasome components (e.g., NLRP3, ASC, and caspase-1) through oxidative modifications. During ERS, the release of Ca<sup>2+</sup> from the ER is a crucial signaling event. After entering the cytosol, Ca<sup>2+</sup> activates calcineurin, which in turn regulates the activity of transcription factors including NF-κB. Once activated, NF-κB directly binds to the promoter region of the NLRP3 gene, facilitating its transcription and thereby promoting the expression of NLRP3 inflammasome-related genes. Importantly, ERS also promotes physical contact between the ER and mitochondria through dysregulation of calcium signaling [<a href="#CIT0041" class="usa-link" aria-describedby="CIT0041">41</a>,<a href="#CIT0095" class="usa-link" aria-describedby="CIT0095">95</a>].</p></section><section id="S0004-S2002-S3004"><h4 class="pmc_sec_title">4.2.4. Other organelles</h4>
<p>As a central organelle for protein processing, modification, and transport, the Golgi apparatus has emerged as a key player in inflammation activation. Recent studies show that golgi-targeted photodynamic therapy significantly up-regulates NLRP3 expression and promotes release of pro-inflammatory cytokines (e.g., IL-1β, IL-18), underscoring its critical role in NLRP3 inflammasome activation. While the regulatory mechanisms between the golgi and NLRP3 remain partially elucidated, cross-organelle crosstalk—including interactions with the ER and mitochondria—is recognized as central to NLRP3 inflammasome priming and assembly. Zhang et al. demonstrated that upon NLRP3 inflammasome activation, mitochondria-associated membranes localize adjacent to the Golgi, coinciding with increased Golgi diacylglycerol levels [<a href="#CIT0096" class="usa-link" aria-describedby="CIT0096">96</a>]. This triggers recruitment and activation of protein kinase D, which phosphorylates NLRP3. Phosphorylated NLRP3 dissociates from mitochondria-associated membranes and undergoes ordered cytoplasmic assembly into functional inflammations. This pathway confirms that Golgi-mediated protein kinase D signaling is indispensable for NLRP3 inflammasome activation [<a href="#CIT0097" class="usa-link" aria-describedby="CIT0097">97</a>].</p>
<p>Notably, current research on NLRP3 inflammasomes in CKD has primarily focused on mitochondria, ER, and lysosomes, or their collaborative interactions.</p></section></section><section id="S0004-S2003"><h3 class="pmc_sec_title">4.3. Cell pyroptosis and pan-apoptosis</h3>
<p>Pyroptosis is a type of programmed cell death that depends on inflammatory caspases, chiefly caspase-1, 4, 5, and It is marked by cell swelling and the secretion of pro-inflammatory cytokines. The activation of the NLRP3 inflammasome can induce pyroptosis in renal cells, whereas its inhibition can decelerate this process, hence mitigating the advancement of CKD [<a href="#CIT0098" class="usa-link" aria-describedby="CIT0098">98–100</a>]. Li et al. found that Bushen Huoxue Granule can effectively block the activation of the NLRP3 inflammasome triggered by angiotensin II in human proximal tubular epithelial cells (HK-2 cells), thus reducing renal fibrosis and pyroptosis [<a href="#CIT0101" class="usa-link" aria-describedby="CIT0101">101</a>].</p>
<p>PANoptosis is a newly discovered form of inflammatory programmed cell death that involves the interactions and communications among pyroptosis, apoptosis, and necroptosis [<a href="#CIT0102" class="usa-link" aria-describedby="CIT0102">102</a>]. This procedure has garnered increased attention in recent years. Among them, necroptosis represents a distinct form of programmed necrotic cell death characterized by prominent cellular swelling, plasma membrane rupture, and the subsequent release of intracellular contents. Notably, DAMPs such as ATP, released by necroptotic cells, play a pivotal role in activating the NLRP3 inflammasome. Specifically, ATP mediates K<sup>+</sup> efflux through the P2X 7 receptor, a critical upstream event that initiates NLRP3 inflammasome assembly and subsequent pyroptosis [<a href="#CIT0103" class="usa-link" aria-describedby="CIT0103">103</a>]. PANoptosis may affect the expression of inflammatory factors in RTEC. The pan-apoptotic pathway may be closely associated with the NLRP3 inflammasome. In the TAK1 knockout mouse model, the inhibition or deletion of TAK1 results in pan-apoptosis mediated by the receptor-interacting protein kinase 1-PANoptosome complex. This complex includes the NLRP3 inflammasome along with critical components such as caspase-8, fas-associated death domain, and receptor-interacting protein kinase 3 [<a href="#CIT0043" class="usa-link" aria-describedby="CIT0043">43</a>]. More <em>in vivo</em> and <em>in vitro</em> experiments are needed in the future to fully understand how pan-apoptosis and the NLRP3 inflammasome work in nephrology.</p></section><section id="S0004-S2004"><h3 class="pmc_sec_title">4.4. Ferroptosis</h3>
<p>Ferroptosis is a form of programmed cell death first proposed in 2012 [<a href="#CIT0104" class="usa-link" aria-describedby="CIT0104">104</a>]. It is a new iron-dependent non-apoptotic cell death pathway and is distinct from traditional cell death modes such as apoptosis, pyroptosis, and necrosis. Ferroptosis is characterized by the excessive accumulation of lipid peroxides and ROS. Recent research has shown that reducing ferroptosis in RTEC can reduce the occurrence of renal fibrosis, therefore contributing to the deceleration of CKD progression [<a href="#CIT0105" class="usa-link" aria-describedby="CIT0105">105–107</a>].</p>
<p>A complicated relationship may exist between ferroptosis and NLRP3. Ferroptosis can initiate the activation of the NLRP3 inflammasome [<a href="#CIT0108" class="usa-link" aria-describedby="CIT0108">108</a>], which subsequently intensifies ferroptosis [<a href="#CIT0109" class="usa-link" aria-describedby="CIT0109">109</a>]. The interplay between ferroptosis and NLRP3 in CKD is significant. CD1c<sup>+</sup> dendritic cells (CD1c<sup>+</sup> DCs), a subset of myeloid dendritic cells (mDCs), are capable of sensing pathogen-associated and damage-derived signals to initiate immune responses. They also secrete various cytokines and chemokines such as IL-12, IL-6, and TNF-α, playing a critical role in renal inflammation. Giuliani et al. discovered that ferroptosis transpired in HK-2 cells under hypoxic conditions, and the activation of the NLRP3 inflammasome was noted in CD1c dendritic cells. The researchers also noted that in the vicinity of ferroptotic HK-2 cells, interstitial CD1c<sup>+</sup> DCs containing ASC speckles exhibit significant accumulation. Treatment with the NLRP3 inhibitor Monash Chemical Compound 950 (MCC950) or genetic knock down of NLRP3 significantly suppresses the maturation and secretion of IL-1β/IL-18 in DCs, while attenuating DC maturation phenotypes and Th1 cell polarization capacity. In the kidneys of mice lacking endothelial-cell-specific Atg7, there was an enhanced buildup of ferritin and upregulation of the NLRP3 inflammasome signaling pathway [<a href="#CIT0110" class="usa-link" aria-describedby="CIT0110">110</a>]. Pharmacological reduction of ferroptosis can restore the compromised endothelial barrier and reverse the diminished expression of NLRP3 and IL-1β in the aging murine model, hence mitigating renal tubulointerstitial fibrosis. These findings demonstrate the link between the NLRP3 inflammasome and ferroptosis in CKD. Lipid peroxidation serves as a crucial ‘intermediate stage’ in the induction of ferroptosis [<a href="#CIT0111" class="usa-link" aria-describedby="CIT0111">111</a>]; yet, its specific manner of action on the NLRP3 inflammasome remains inadequately clarified within the current understanding of ferroptosis mechanisms. Ferroptosis may concurrently have a synergistic effect with other forms of cell death, including pyroptosis [<a href="#CIT0112" class="usa-link" aria-describedby="CIT0112">112</a>].</p></section><section id="S0004-S2005"><h3 class="pmc_sec_title">4.5. Intestinal flora metabolism</h3>
<p>The gut-kidney axis is a bidirectional signaling network that encompasses the kidney, gut, and its microbiome. The gut-kidney axis idea, derived from ‘enterorenal syndrome,’ was formally created by Meijers in 2011 [<a href="#CIT0113" class="usa-link" aria-describedby="CIT0113">113</a>], providing a novel framework for comprehending the interplay between the intestine and the kidney. CKD generally results in dysbiosis of the gut microbiota, leading to elevated concentrations of uremic toxins and intestinal bacteria in the bloodstream. This cascade triggers an inflammatory response characterized by the production of ROS and the release of pro-inflammatory cytokines, thereby accelerating renal fibrosis.</p>
<p>The onset and advancement of CKD may be related to disrupted bidirectional communication between NLRP3 and gut microbiota. An imbalance in intestinal flora may trigger the NLRP3 inflammasome by bacterial toxins in the gut, ultimately leading to inflammatory reactions [<a href="#CIT0114" class="usa-link" aria-describedby="CIT0114">114</a>]. Inhibiting the activation of the NLRP3 inflammasome pathway may aid in reestablishing the equilibrium of intestinal microbiota and decelerating the progression of CKD. Recent studies have shown that increased uric acid levels might disturb intestinal microbiota balance and activate the NLRP3 inflammasome, resulting in renal impairment. The knockout of the NLRP3 gene decreased the severity of renal injury, verifying the critical role of NLRP3 activation in this phenomenon [<a href="#CIT0044" class="usa-link" aria-describedby="CIT0044">44</a>,<a href="#CIT0115" class="usa-link" aria-describedby="CIT0115">115</a>].</p>
<p>Short-chain fatty acids (SCFAs), produced by gut microbiota, have shown the capacity to suppress the production and activation of NLRP3 inflammasomes. In a rat model of diabetic nephropathy, red ginseng berry decreased kidney tissue fibrosis by suppressing NLRP3 inflammasomes. Red ginseng berry enhances intestinal barrier protection and increases beneficial intestinal flora, which is essential for regulating the production of SCFAs [<a href="#CIT0116" class="usa-link" aria-describedby="CIT0116">116</a>]. An investigation employing a rat model of CKD revealed that exogenous butyrate supplementation, a short-chain fatty acid, significantly decreased the expression levels of various critical proteins linked to NLRP3 inflammasome-mediated pyroptosis, such as NLRP3, IL-1β, caspase-1, and GSDMD. This intervention significantly reduced renal fibrosis. <em>In vitro</em> tests with HK-2 cells showed that adding butyrate greatly decreased the rise in NLRP3-mediated pyroptosis protein levels after TGF-β1 stimulation. This supported the idea that SCFAs can stop NLRP3 inflammasomes from forming [<a href="#CIT0117" class="usa-link" aria-describedby="CIT0117">117</a>]. These findings indicate that NLRP3 inflammasome may play a role in the progression of renal fibrosis through mechanisms involving the gut-kidney axis and gut microbiota interactions.</p>
<p>Altering the gut microbiota with therapies such as probiotics and prebiotics may improve the management of kidney disease [<a href="#CIT0118" class="usa-link" aria-describedby="CIT0118">118</a>,<a href="#CIT0119" class="usa-link" aria-describedby="CIT0119">119</a>]. Probiotics are a category of functional microorganisms based on the theory of microecological balance, which exerts beneficial effects on host health when ingested in sufficient quantities. Specifically, probiotics can stimulate intestinal epithelial cells to secrete mucus and antimicrobial peptides, enhancing the intestinal mucosal barrier function to prevent PAMPs from activating the NLRP3 inflammasome. Additionally, they produce metabolic byproducts such as SCFAs, which inhibit NLRP3 inflammasome activation and regulate intestinal immune homeostasis. Prebiotics, as substrates for probiotics, can be selectively utilized by these microorganisms to promote their proliferation in the intestinal tract. In conclusion, these studies indicate that the NLRP3 inflammasome may affect renal fibrosis <em>via</em> the intestine-renal axis and the interaction between intestinal microbiota, presenting additional potential avenues for CKD treatment.</p></section><section id="S0004-S2006"><h3 class="pmc_sec_title">4.6. Negative activation mechanisms</h3>
<p>In addition to the above activation mechanisms, multiple negative feedback pathways exist within cells to maintain the dynamic balance of the NLRP3 inflammasome, which provides new directions for the treatment of CKD.</p>
<p>Autophagy is considered a negative regulator of the NLRP3 inflammasome. The term ‘autophagy’ was coined by Christian de Duve in 1963. It refers to a cellular degradation process where autophagosomes form to engulf damaged organelles and misfolded proteins, subsequently fuzing with lysosomes to degrade them and maintain cellular homeostasis [<a href="#CIT0120" class="usa-link" aria-describedby="CIT0120">120</a>]. Activating autophagy aids in removing damaged organelles and protein aggregates, reduces cell death and inflammation, and regulates the synthesis and degradation of the extracellular matrix, thereby improving renal function and slowing the progression of renal fibrosis [<a href="#CIT0121" class="usa-link" aria-describedby="CIT0121">121</a>]. Research reveals that autophagy can restrict the activation of the NLRP3 inflammasome, thus preventing sustained inflammation. The specific mechanisms involve the degradation of NLRP3 inflammasome components by autophagosomes, the clearance of damaged mitochondria to reduce intracellular ROS levels, and the degradation of metabolites like cholesterol crystals and uric acid crystals to prevent their activation of the NLRP3 inflammasome. Atg5, a member of the autophagy-related gene family, forms an essential Atg5-Atg12 complex for autophagosome membrane elongation and closure. Compared to NRK-52E cells, NRK-Atg5-(2) cells with reduced Atg5 expression show significantly upregulated NLRP3, caspase-1, fibronectin, and α-smooth muscle actin. This implies that lowered Atg5 may boost NLRP3 expression, worsening renal inflammation and fibrosis [<a href="#CIT0122" class="usa-link" aria-describedby="CIT0122">122</a>]. However, current research on autophagy’s role in regulating the NLRP3 inflammasome to slow CKD progression remains limited. Future studies should explore this link further to identify potential therapeutic targets and strategies for CKD treatment.</p>
<p>Transcriptomic research indicates that microRNAs may negatively regulate NLRP3 activation. These endogenous small non-coding RNAs suppress specific target gene expression post-transcriptionally and play a key role in regulating kidney inflammation, cell injury, fibrosis, and epithelial-mesenchymal transition. In <em>db/db</em> and STZ-treated diabetic nephropathy mice, miR-10a/b curbs NLRP3 inflammasome activation, reducing pro-inflammatory cytokines IL-1β and IL-This notably improves renal inflammation and alleviates albuminuria. Conversely, miR-10a/b CKD boosts NLRP3 inflammasome activation, exacerbating renal inflammation [<a href="#CIT0123" class="usa-link" aria-describedby="CIT0123">123</a>].</p>
<p>Although negative regulatory mechanisms such as autophagy and microRNAs have been preliminarily revealed, the tissue-specific regulation and intercellular interaction mechanisms of these pathways in the context of CKD still require in-depth study. Targeting the negative regulatory pathways of NLRP3 (such as regulating autophagy or miRNA expression through TCMS may become a new strategy to delay the progression of CKD.</p></section></section><section id="S0005"><h2 class="pmc_sec_title">5. The role of NLPR3 inflammation in different CKDs</h2>
<section id="S0005-S2001"><h3 class="pmc_sec_title">5.1. Diabetic nephropathy</h3>
<p>Diabetic nephropathy (DN) is the primary cause of ESRD. As an inflammatory disease, DN is largely influenced by secreted inflammatory mediators. The activation of the NLRP3 inflammasome is closely associated with several pathological characteristics of DN, such as glomerular injury, renal interstitial fibrosis, and proteinuria. Inhibiting the activation of the NLRP3 inflammasome can help mitigate the pathological damage caused by DN. Inhibiting the activation of the NLRP3 inflammasome helps alleviate pathological damage in DN [<a href="#CIT0124" class="usa-link" aria-describedby="CIT0124">124</a>].</p>
<p>Diabetic metabolic abnormalities, such as hyperglycemia, hyperlipidemia, and elevated free fatty acids, can directly or indirectly trigger the NLRP3 inflammasome. This activation results in the release of IL-1β and IL-18, leading to damage in islet cells, insulin resistance, and systemic inflammation. Studies have demonstrated that elevated glucose levels can upregulate TXNIP expression and activate the NLRP3 inflammasome in renal tissue of DN rats, increasing levels of inflammatory factors in a time- and dose-dependent manner. Silencing TXNIP has been shown to decrease ROS levels and inhibit NLRP3 inflammasome activation [<a href="#CIT0125" class="usa-link" aria-describedby="CIT0125">125</a>]. NF-κB p65 is a crucial element of the nuclear factor-kappa B family. It operates as a transcription factor, modulating inflammatory responses. NF-κB p65 is activated downstream of the ROS/NLRP3 signaling pathway and then transferred to the nucleus, which subsequently regulates the transcription of a series of inflammation-related genes. Wu et al. revealed that inhibiting NLRP3 inflammasome activation significantly diminishes NF-κB p65 activation and mtROS generation in podocytes exposed to elevated glucose levels [<a href="#CIT0126" class="usa-link" aria-describedby="CIT0126">126</a>]. This emphasizes the essence of the NLRP3/ROS/NF-κB p65 pathway in the accumulation of lipids associated with diabetes in podocytes. In recent years, studies have found that there may be new regulatory mechanisms between ROS, NF-κB, and the NLRP3 inflammasome. Optineurin can participate in the regulation of the NF-κB signaling pathway. Studies have shown that silencing the optineurin gene in mouse RTEC increased mtROS and led to activation of the NLRP3 inflammasome in a high glucose environment. By enhancing mitophagy, overexpression of the optineurin gene can inhibit the activation of the NLRP3 inflammasome [<a href="#CIT0127" class="usa-link" aria-describedby="CIT0127">127</a>]<sup>.</sup> In addition, a recent study revealed that the suppression of toll-like receptor 9 gene expression in diabetic nephropathy mice can also effectively inhibit the activation of NF-κB and NLRP3 inflammasome pathways, thereby reducing the expression of inflammatory and apoptotic factors [<a href="#CIT0128" class="usa-link" aria-describedby="CIT0128">128</a>].</p></section><section id="S0005-S2002"><h3 class="pmc_sec_title">5.2. Hypertensive nephropathy</h3>
<p>Hypertensive nephropathy is the second leading cause of CKD after DN. Angiotensin II (Ang II), a fundamental element of the renin-angiotensin system, is a crucial regulator of hypertensive nephropathy. By activating the NLRP3 inflammasome, previous studies have suggested that Ang II plays a role in the pathological process of renal fibrosis. A recent study suggested that TGF-β-mediated NLRP3 inflammasome activation may trigger the release of high-mobility group box 1, thereby exacerbating the pathological progression of Ang II-induced renal fibrosis in hypertensive nephropathy. However, further experiments confirmed that TGF-β rather than Ang II-induced NLRP3 protein expression, indicating that there may not be a direct relationship between NLRP3 and Ang II [<a href="#CIT0129" class="usa-link" aria-describedby="CIT0129">129</a>]. Another study found that the NLRP3 activity inhibitor MCC950 can lower blood pressure in mice and reduce kidney inflammation, fibrosis, and dysfunction in hypertensive mice [<a href="#CIT0130" class="usa-link" aria-describedby="CIT0130">130</a>]. This finding suggests that inhibiting NLRP3 activation may attenuate the progression of hypertensive nephropathy.</p>
<p>Moreover, the intricate interplay between NLRP3 and gut microbiota plays a role in the pathological progression of hypertensive nephropathy. Experimental data indicates that butyric acid can markedly suppress the expression of NLRP3 inflammasome-related proteins triggered by Ang II, thus mitigating the inflammatory response mediated by the NF-κB/IL-1β signaling pathway and decreasing pyroptosis [<a href="#CIT0131" class="usa-link" aria-describedby="CIT0131">131</a>]. This ultimately exerts a beneficial effect on hypertensive nephropathy. Looking ahead, interventions aimed at the NLRP3 inflammasome may offer novel therapeutic targets for the treatment of hypertensive nephropathy.</p></section><section id="S0005-S2003"><h3 class="pmc_sec_title">5.3. IgA nephropathy</h3>
<p>IgA nephropathy(IgAN) is a highly widespread primary glomerular disease worldwide and is regarded as a leading cause of ESRD. The syndrome is characterized by the buildup of immunological complexes mostly consisting of IgA within the glomerular tunica albuginea. The exact cause and pathology of IgAN are still not fully understood, but NLRP3 inflammasomes are seen as promising therapeutic targets [<a href="#CIT0132" class="usa-link" aria-describedby="CIT0132">132</a>].</p>
<p>NLRP3 inflammasomes are shown to be significantly linked to the pathological process of IgAN. Renal macrophages and thylakoid cells are implicated in the pathogenesis of IgAN [<a href="#CIT0133" class="usa-link" aria-describedby="CIT0133">133</a>]. IgA immune complexes induce mtROS production in macrophages, subsequently activating NLRP3 inflammasomes. IgA immune complexes directly activate NLRP3 inflammasomes in renal parenchymal cells, such as thylakoid cells and renal tubular epithelial cells, leading to a localized renal inflammatory response. Renal tubular injury and interstitial fibrosis are significant factors in the progression of IgAN [<a href="#CIT0022" class="usa-link" aria-describedby="CIT0022">22</a>,<a href="#CIT0134" class="usa-link" aria-describedby="CIT0134">134</a>]. The expression level of NLRP3 in glomeruli and tubules is significantly elevated in renal biopsy tissues from IgAN patients compared to normal renal tissues [<a href="#CIT0135" class="usa-link" aria-describedby="CIT0135">135</a>]. This expression may exhibit an inverse correlation with the severity of renal insufficiency and the quantity of proteinuria. The inhibition of NLRP3 expression has been shown to reverse proteinuria, enhance renal function, and reduce renal lesions in an IgAN model, indicating that the activation of NLRP3 inflammasome is crucial in the pathological progression of this disease [<a href="#CIT0132" class="usa-link" aria-describedby="CIT0132">132</a>].</p>
<p>Although previous studies have predominantly indicated that NLRP3 expression in IgAN is concentrated in macrophages, tethered cells and renal tubular epithelial cells, among other cell types, a recent <em>ex vivo</em> study unveils a novel role localization of NLRP3 expression in podocytes and suggests that IgA deposition induces NLRP3 expression in podocytes as well as macrophage transdifferentiation [<a href="#CIT0136" class="usa-link" aria-describedby="CIT0136">136</a>]. In addition, a study in IgAN patients demonstrated that inhibition of the NLRP3/ASC/caspase-1 signaling pathway by probiotic supplementation significantly ameliorated intestinal dysbiosis and ameliorated IgAN, revealing complex interactions between NLRP3 and intestinal flora in IgA [<a href="#CIT0137" class="usa-link" aria-describedby="CIT0137">137</a>]. These changes may influence the immunoregulation and pathological course of IgAN.</p></section><section id="S0005-S2004"><h3 class="pmc_sec_title">5.4. Hyperuricemic nephropathy</h3>
<p>Hyperuricemic nephropathy is a renal disease directly caused by hyperuricemia. The condition is characterized by decreased renal function, tubulointerstitial fibrosis, and inflammation. Hyperuricemia is now acknowledged as an independent risk factor for an unfavorable prognosis in patients with CKD [<a href="#CIT0138" class="usa-link" aria-describedby="CIT0138">138</a>].</p>
<p>The NLRP3 inflammasome is an important player in the development of hyperuricemia nephropathy. Soluble uric acid and its crystals deposited in kidney tissue can act as DAMPs to activate the NLRP3 inflammasome, which in turn triggers the release of inflammatory mediators. Inhibiting NLRP3 activation has been shown to slow the progression of hyperuricemic nephropathy [<a href="#CIT0139" class="usa-link" aria-describedby="CIT0139">139</a>]. Hu et al. showed that by disrupting the autophagy-NLRP3 pathway, uric acid-induced pyroptosis could be mitigated effectively, thus preventing the onset of hyperuricemia nephropathy [<a href="#CIT0140" class="usa-link" aria-describedby="CIT0140">140</a>]. Wu et al. demonstrated that Shizhifang downregulated the gene and protein expression of the NLRP3 inflammasome by modulating the ROS-TXNIP pathway, thereby reducing renal tubule damage and inflammatory response in hyperuricemia rats [<a href="#CIT0141" class="usa-link" aria-describedby="CIT0141">141</a>]. Lin et al. uncovered that Bi Xie Fen Qing Yin decoction could inhibit NLRP3 inflammasome activation by modulating intestinal flora, consequently impeding renal fibrosis in the hyperuricemic nephropathy model [<a href="#CIT0142" class="usa-link" aria-describedby="CIT0142">142</a>]. Nonetheless, current research on hyperuricemia nephropathy predominantly relies on animal models and cell studies, underscoring the pressing need for more extensive clinical trials in the future.</p></section><section id="S0005-S2005"><h3 class="pmc_sec_title">5.5. Obesity-Associated kidney disease</h3>
<p>Obesity-associated kidney disease (OAKD) is a secondary glomerular condition linked to obesity and is a significant risk factor for CKD, with the risk of ESRD increasing with a higher body mass index (BMI) [<a href="#CIT0143" class="usa-link" aria-describedby="CIT0143">143</a>].</p>
<p>In a study by Boini et al. in 2014, heightened expression of NLRP3 inflammasome components was observed in damaged podocytes in a mouse model of obesity-induced glomerulopathy from a high-fat diet, indicating activation of the NLRP3 inflammasome [<a href="#CIT0144" class="usa-link" aria-describedby="CIT0144">144</a>]. Hou et al. identified that the purinergic 2 × 7 receptor could induce podocyte injury in OAKD by activating the NLRP3 inflammasome, as demonstrated through additional <em>in vitro</em> cell studies and <em>in vivo</em> mouse models [<a href="#CIT0145" class="usa-link" aria-describedby="CIT0145">145</a>]. Furthermore, in obesity, there is an increase in inflammatory mediators such as TNF-α and IL-6 released by adipose tissue, coupled with a decrease in adiponectin levels, resulting in systemic chronic low-grade inflammation. Research has shown that adiponectin can suppress the expression of NLRP3 inflammasome-related factors and alleviate renal podocyte injury induced by free fatty acids <em>in vitro</em> [<a href="#CIT0146" class="usa-link" aria-describedby="CIT0146">146</a>]. Presently, investigations on NLRP3 in OAKD predominantly concentrate on its downstream components, with additional pathways necessitating further investigation in future studies.</p></section><section id="S0005-S2006"><h3 class="pmc_sec_title">5.6. Obstructive nephropathy</h3>
<p>The unilateral ureteral obstruction (UUO) model induces increased kidney pressure by obstructing one ureter, resulting in pathological changes resembling those observed in CKD, including inflammation, apoptosis, and fibrosis [<a href="#CIT0147" class="usa-link" aria-describedby="CIT0147">147</a>]. This model is widely used in CKD research. Studies have demonstrated a significant upregulation of NLRP3 inflammasome expression in UUO-induced kidney disease, which correlates positively with renal fibrosis severity [<a href="#CIT0148" class="usa-link" aria-describedby="CIT0148">148</a>]. Stimulation of renal mitochondria by NLRP3 agonists leads to the generation of ROS, triggering NLRP3 inflammasome assembly and promoting the release of inflammatory mediators [<a href="#CIT0149" class="usa-link" aria-describedby="CIT0149">149</a>]. Knocking out the NLRP3 gene in a mouse UUO model resulted in reduced renal injury and fibrosis, underscoring the pivotal role of the NLRP3 inflammasome in UUO-induced kidney fibrosis [<a href="#CIT0149" class="usa-link" aria-describedby="CIT0149">149</a>]. However, further confirmation of these findings is necessary through additional clinical trials.</p></section><section id="S0005-S2007"><h3 class="pmc_sec_title">5.7. Other chronic kidney diseases</h3>
<p>Lupus nephritis (LN) is the most common and severe renal manifestation of systemic lupus erythematosus, classified as an autoimmune glomerulopathy. In systemic lupus erythematosus patients, antinuclear antibodies (such as anti-double-stranded DNA antibodies)bind to glomerular antigens to form immune complexes, which activate the complement system and trigger glomerular inflammation and injury. If left uncontrolled, LN can lead to glomerulosclerosis, tubular atrophy, and renal interstitial fibrosis, ultimately progressing to CKD. Approximately 20%-30% of LN patients will develop ESRD within 10–15 years [<a href="#CIT0120" class="usa-link" aria-describedby="CIT0120">120</a>]. The NLRP3 inflammasome is a key contributor to the pathogenesis of LN. Previous research has shown elevated expression of the NLRP3 inflammasome in LN patients, with levels of NLRP3 protein positively correlating with serum creatinine, urine protein, and renal pathology [<a href="#CIT0150" class="usa-link" aria-describedby="CIT0150">150</a>]. Animal studies have demonstrated that silencing or inhibiting NLRP3 can significantly reduce renal damage in LN mice. Liu et al. reported that knockout of guanylate-binding protein 5 suppressed NLRP3 inflammasome activation and secretion of IL-1β and IL-18, leading to decreased proteinuria, blood urea nitrogen, and creatinine levels, improved renal pathology, and slowed LN progression [<a href="#CIT0151" class="usa-link" aria-describedby="CIT0151">151</a>]. Yang et al. confirmed that magnolol can mitigate LN by enhancing autophagy and suppressing NLRP3 inflammasome activation [<a href="#CIT0152" class="usa-link" aria-describedby="CIT0152">152</a>]. Furthermore, early investigations have shown NLRP3 inflammasome activation in uremic patients undergoing dialysis, possibly triggered by mitochondrial dysfunction (<a href="#t0001" class="usa-link">Table 1</a>) [<a href="#CIT0153" class="usa-link" aria-describedby="CIT0153">153</a>].</p>
<section class="tw xbox font-sm" id="t0001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>The Role of NLRP3 in CKD.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
</colgroup>
<thead><tr>
<th align="left" colspan="1" rowspan="1">Disease</th>
<th align="center" colspan="1" rowspan="1">Relevant factors</th>
<th align="center" colspan="1" rowspan="1">Animal or cell</th>
<th align="center" colspan="1" rowspan="1">Role</th>
<th align="center" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1">Diabetic Nephropathy</td>
<td align="left" colspan="1" rowspan="1">IL-1β↑,IL-18↑,ASC↑,<br>caspase-1↑,NLRP3↑</td>
<td align="left" colspan="1" rowspan="1">Diabetic nephropathy mice</td>
<td align="left" colspan="1" rowspan="1">Cellular focal death, mitochondrial damage, autophagy, glomerular injury, interstitial fibrosis and proteinuria</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0125" class="usa-link" aria-describedby="CIT0125">125</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hypertensive Nephropathy</td>
<td align="left" colspan="1" rowspan="1">IL-1β↑,IL-18↑,ASC↑,<br>caspase-1↑,NLRP3↑</td>
<td align="left" colspan="1" rowspan="1">Hypertensive nephropathy mice</td>
<td align="left" colspan="1" rowspan="1">Kidney damage and fibrosis</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0129" class="usa-link" aria-describedby="CIT0129">129</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IgA Nephropathy</td>
<td align="left" colspan="1" rowspan="1">NLRP3↑,ASC↑,caspase-1↑,IL-1β↑, IL-18↑</td>
<td align="left" colspan="1" rowspan="1">NLRP3−/− mice</td>
<td align="left" colspan="1" rowspan="1">Proteinuria and improve renal function damage</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0132" class="usa-link" aria-describedby="CIT0132">132</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hyperuricemic Nephropathy</td>
<td align="left" colspan="1" rowspan="1">NLRP3↑,ASC↑,caspase-1↑, GSDMD↑, ROS↑,TXNIP↑</td>
<td align="left" colspan="1" rowspan="1">Hyperuricemic nephropathy rat, RTEC</td>
<td align="left" colspan="1" rowspan="1">Cell death, gut flora damage, kidney injury and renal fibrosis</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0140" class="usa-link" aria-describedby="CIT0140">140–142</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Obesity-Associated Kidney Disease</td>
<td align="left" colspan="1" rowspan="1">ASC↑,caspase-1↑,NLRP3↑,Purinergic Receptor P2X 7 R↑</td>
<td align="left" colspan="1" rowspan="1">ORG mice</td>
<td align="left" colspan="1" rowspan="1">Podocyte injury</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0145" class="usa-link" aria-describedby="CIT0145">145</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Obstructive Nephropathy</td>
<td align="left" colspan="1" rowspan="1">ASC↑,caspase-1↑,IL-1β↑,NLRP3↑</td>
<td align="left" colspan="1" rowspan="1">UUO mice,NLRP3−/− mice</td>
<td align="left" colspan="1" rowspan="1">Kidney damage and fibrosis</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0149" class="usa-link" aria-describedby="CIT0149">149</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lupus Nephritis</td>
<td align="left" colspan="1" rowspan="1">NLRP3↑,ASC↑,caspase-1↑,IL-1β↑, IL-18↑</td>
<td align="left" colspan="1" rowspan="1">GBP5MRL/<em>lpr</em> mice, HK-2 cells</td>
<td align="left" colspan="1" rowspan="1">Urine proteinuria, blood urea nitrogen, creatinine levels, renal damage</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0151" class="usa-link" aria-describedby="CIT0151">151</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="S0006"><h2 class="pmc_sec_title">6. Traditional Chinese medicines</h2>
<section id="S0006-S2001"><h3 class="pmc_sec_title">6.1. Active ingredients of traditional Chinese medicines</h3>
<p>Astragaloside IV is a significant bioactive compound present in the Chinese herbal medicine <em>Astragalus membranaceus</em> [<a href="#CIT0154" class="usa-link" aria-describedby="CIT0154">154</a>]. It plays a crucial role in retarding the advancement of CKD by mitigating inflammatory responses, reducing apoptosis, and ameliorating oxidative stress [<a href="#CIT0155" class="usa-link" aria-describedby="CIT0155">155–157</a>]. Li et al. demonstrated that Astragaloside IV hinders the activation of the NLRP3 inflammasome by diminishing ROS production, consequently suppressing the release of the inflammatory cytokine IL-1β in RTEC. As a result, this action diminishes tubulointerstitial inflammation and decelerates the progression of DN [<a href="#CIT0158" class="usa-link" aria-describedby="CIT0158">158</a>]. These findings indicate that astragaloside IV can impede the activation of the NLRP3 inflammasome by improving oxidative stress, as a potential mechanism for managing kidney diseases.</p>
<p>Panax notoginseng saponins (PNS), sourced from <em>Panax notoginseng</em>, a traditional Chinese herbal remedy, are known for their significant role in modulating renal fibrosis. Xie et al. demonstrated that PNS effectively reduced blood levels of inflammatory proteins NF-κB p65, NLRP3, IL-1β, and IL-18 in adenine-induced CKD rats while inhibiting the progression of inflammation and fibrosis in renal tissue by modulating gut microbiota and suppressing the activation of renal pro-inflammatory and pro-fibrotic proteins [<a href="#CIT0159" class="usa-link" aria-describedby="CIT0159">159</a>]. In a lipopolysaccharide-induced HK-2 cells fibrosis model, PNS attenuated renal fibrosis by suppressing NLRP3 inflammasome activation and cellular pyroptosis. PNS and NLRP3 inflammasome have shown promising results in the treatment of kidney disease through these modes of action [<a href="#CIT0160" class="usa-link" aria-describedby="CIT0160">160</a>].</p>
<p>Honokiol is an allyl-substituted biphenyl diphenol molecule that serves as the principal active component of the traditional Chinese medication Magnolia [<a href="#CIT0161" class="usa-link" aria-describedby="CIT0161">161</a>]. Recent research indicates that honokiol positively influences the course of CKD through many mechanisms, including anti-inflammatory, antioxidant, and antifibrotic activities [<a href="#CIT0162" class="usa-link" aria-describedby="CIT0162">162</a>]. Ma et al. reported in a study utilizing MRL/<em>lpr</em> model mice that honokiol inhibited the activation of NLRP3 inflammasomes in the kidneys, thereby mitigating renal damage and pathological alterations in the animals [<a href="#CIT0163" class="usa-link" aria-describedby="CIT0163">163</a>]. Moreover, honokiol has demonstrated efficacy in alleviating lupus nephritis by obstructing the NLRP3/IL-33/ST2 signaling pathway, thereby mitigating the abnormal interactions between renal resident macrophages and RTEC [<a href="#CIT0164" class="usa-link" aria-describedby="CIT0164">164</a>].</p>
<p>Pterostilbene is a natural dimethoxy analog present in various plant sources like blueberries, grapes, and pine trees [<a href="#CIT0165" class="usa-link" aria-describedby="CIT0165">165</a>]. Pterostilbene has been shown to possess renal protective properties by reducing oxidative stress and fibrosis, potentially through modulation of the TGF-β1/Smads signaling pathway [<a href="#CIT0166" class="usa-link" aria-describedby="CIT0166">166</a>,<a href="#CIT0167" class="usa-link" aria-describedby="CIT0167">167</a>]. Additionally, pterostilbene has emerged as a potent inducer of autophagy in cellular systems. Wang et al. illustrated pterostilbene’s ability to trigger autophagy in a murine model of urate nephropathy, leading to the inhibition of TGF-β-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition, consequently impeding renal fibrosis progression [<a href="#CIT0122" class="usa-link" aria-describedby="CIT0122">122</a>]. These findings underscore the therapeutic promise of pterostilbene in managing CKD.</p>
<p>Triptolide is a vital active compound derived from <em>Tripterygium wilfordii</em>, a traditional Chinese medicinal plant. Triptolide effectively inhibits the assembly and activation of the NLRP3 inflammasome, leading to a reduction in the expression levels of downstream effector molecules like caspase-1, IL-1β, and IL-18. This inhibition results in decreased renal inflammatory responses [<a href="#CIT0168" class="usa-link" aria-describedby="CIT0168">168</a>]. Lv et al. have illustrated that in DN mouse models, activation of the nuclear factor-erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 pathway can alleviate oxidative stress and reduce ROS production. Furthermore, it can impede the NLRP3 inflammasome pathway, thus alleviating pyroptosis and diabetic nephropathy podocyte injury [<a href="#CIT0169" class="usa-link" aria-describedby="CIT0169">169</a>]. Triptolide mitigates oxidative stress and pyroptosis through the Nrf2/ROS/NLRP3 axis, ultimately enhancing renal function and ameliorating histopathological damage in DN mice.</p></section><section id="S0006-S2002"><h3 class="pmc_sec_title">6.2. Traditional chinese medicines prescriptions</h3>
<p>Few studies have investigated the impact of TCMS prescriptions on regulating the NLRP3 inflammasome in CKD.</p>
<p>Simiao Powder (SMM), a derivative of Ermiao Powder containing <em>Achyranthes bidentata</em> and <em>Coicis Semen</em>, has shown renal protective properties [<a href="#CIT0170" class="usa-link" aria-describedby="CIT0170">170</a>]. A recent study by Shui et al. revealed that SMM may alleviate kidney injury by modulating NLRP3 inflammasome activation. In a mouse model of hyperuricemia induced by potassium oxalate, SMM downregulated the expression of NLRP3, ASC, and caspase-1, as well as the secretion of IL-1β and IL-18. This inhibition of NLRP3 inflammasome activation by SMM ameliorated hyperuricemia, renal dysfunction, and renal histopathological changes induced by PO [<a href="#CIT0171" class="usa-link" aria-describedby="CIT0171">171</a>]. These findings highlight the potential of SMM in renal protection.</p>
<p>The Bushen Huoxue (BSHX) prescription is a significant formula utilized in CKD treatment, comprising <em>Astragalus mongholicus</em>, <em>Trigonella foenum-graecum L.</em>, <em>Rheum palmatum L.</em>, <em>Vaccaria segetalis</em>, and <em>Curcuma phaeocaulis Val</em>. BSHX prescription is commonly used in clinical practice for CKD management, with studies indicating its efficacy in enhancing renal function. Initial animal studies have demonstrated BSHX’s ability to alleviate renal fibrosis in rats post 5/6 nephrectomy [<a href="#CIT0172" class="usa-link" aria-describedby="CIT0172">172</a>]. Liao’s latest study showed that BSHX prescription could inhibit ROS/NLRP3 inflammasome activation in 5/6 nephrectomy rats, reduce fibrosis and pyroptosis of HK-2 cells induced by NLRP3 overexpression, and ultimately protect renal function [<a href="#CIT0013" class="usa-link" aria-describedby="CIT0013">13</a>]. These findings suggest that BSHX prescription may influence renal oxidative stress and pyroptosis pathways by regulating the NLRP3 inflammasome, thereby offering kidney protection at a molecular level. The potential of BSHX prescription in CKD treatment warrants further investigation (<a href="#t0002" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="t0002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Mechanisms of traditional chinese medicines in the treatment of CKD <em>via</em> NLRP3 inflammasome.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
</colgroup>
<thead><tr>
<th align="left" colspan="1" rowspan="1">Active Ingredients in Chinese Medicines/Complex Chinese Medicines</th>
<th align="center" colspan="1" rowspan="1">Source/<br>composition</th>
<th align="center" colspan="1" rowspan="1">Model</th>
<th align="center" colspan="1" rowspan="1">Mechanism(s)</th>
<th align="center" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1">Astragaloside IV</td>
<td align="left" colspan="1" rowspan="1">
<em>Astragalus membranaces</em>
</td>
<td align="left" colspan="1" rowspan="1">RTEC</td>
<td align="left" colspan="1" rowspan="1">Reduce the generation of ROS to inhibit the activation of the NLRP3 inflammasome.</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0158" class="usa-link" aria-describedby="CIT0158">158</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PNS</td>
<td align="left" colspan="1" rowspan="1">
<em>Panax notoginseng</em>
</td>
<td align="left" colspan="1" rowspan="1">CKD Rat、HK-2 cell</td>
<td align="left" colspan="1" rowspan="1">Reduce NF-κB p65、NLRP3、IL-1β、IL-18 and inhibit NLRP3 inflammatory vesicle activation and cellular pyroptosis</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0160" class="usa-link" aria-describedby="CIT0160">160</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Honokiol</td>
<td align="left" colspan="1" rowspan="1">
<em>Magnolia</em>
</td>
<td align="left" colspan="1" rowspan="1">MRL/<em>lpr</em> mouse model</td>
<td align="left" colspan="1" rowspan="1">Inhibit of the NLRP3 inflammasome activation and NLRP3/IL-33/ST2 signaling pathway</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0164" class="usa-link" aria-describedby="CIT0164">164</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pterostilbene</td>
<td align="left" colspan="1" rowspan="1">Plants such as blueberries, grapes and pine trees</td>
<td align="left" colspan="1" rowspan="1">Hyperuricemic Nephropathy Rat、NRK-52E cell</td>
<td align="left" colspan="1" rowspan="1">Suppress the NLRP3 inflammasome activation and TGF-β-induced epithelial-mesenchymal transition</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0122" class="usa-link" aria-describedby="CIT0122">122</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Triptolide</td>
<td align="left" colspan="1" rowspan="1">
<em>Tripterygium wilfordii</em>
</td>
<td align="left" colspan="1" rowspan="1">DN Rat and DN Podocytes</td>
<td align="left" colspan="1" rowspan="1">Stimulate Nrf2/HO-1, reduce oxidative stress and ROS generation, and prevent the NLRP3 inflammasome pathway to mitigate cellular apoptosis.</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0169" class="usa-link" aria-describedby="CIT0169">169</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SMM</td>
<td align="left" colspan="1" rowspan="1">
<em>Phellodendrn Bark</em>、<em>Rhizoma Atractylodis</em>、<em>Achyranthes bidentata</em> and <em>Coicis Semen</em>
</td>
<td align="left" colspan="1" rowspan="1">Hyperuricemic Nephropathy mouse</td>
<td align="left" colspan="1" rowspan="1">Inhibiti the NLRP3, ASC, and caspase-1 expression, along with the release of IL-1β and IL-18, and improve compromised renal function</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0171" class="usa-link" aria-describedby="CIT0171">171</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BSHX</td>
<td align="left" colspan="1" rowspan="1">
<em>Astragalus mongholicus</em>, <em>Trigonella foenum-graecum L.</em>, <em>Rheum palmatum L.</em>, <em>Vaccaria segetalis</em>, and <em>Curcuma phaeocaulis Val</em>
</td>
<td align="left" colspan="1" rowspan="1">Renal fibrosis cell model and 5/6 nephrectomy rat model</td>
<td align="left" colspan="1" rowspan="1">Inhibit inflammation activation mediated by ROS and NLRP3 to prevent renal fibrosis and cellular death.</td>
<td align="center" colspan="1" rowspan="1">[<a href="#CIT0013" class="usa-link" aria-describedby="CIT0013">13</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="S0007"><h2 class="pmc_sec_title">7. Synthetic drugs</h2>
<p>Since the discovery of the NLRP3 inflammasome, synthetic chemicals targeting this pathway have become a focal point of research. Beyond TCMS extracts and formulations, certain synthetic drugs have demonstrated potential in mitigating CKD by inhibiting NLRP3 inflammasome activation.</p>
<p>Monash Chemical Compound 950 (MCC950), developed by Matt Cooper, is a potent NLRP3 inhibitor that directly interacts with the NLRP3 NACHT domain, blocking ATP hydrolysis and suppressing inflammation assembly and activation. Studies have shown that MCC950 can inhibit NLRP3 activation in <em>db/db</em> mice and high-glucose-induced mesangial cells, reducing active caspase-1 and IL-1β levels. Additionally, it lowers serum creatinine, urine albumin-to-creatinine ratio, and neutrophil gelatinase-associated lipocalin, while downregulating TGF-β1, fibronectin, collagen I, and α-SMAD, suggesting a potential therapeutic strategy for diabetic nephropathy. In a cisplatin-induced renal fibrosis model, MCC950 was found to significantly alleviate renal dysfunction, tubular injury, interstitial collagen deposition, and profibrotic factor expression by inhibiting NLRP3 inflammasome activation. This ultimately reduces cisplatin-induced renal fibrosis by mitigating oxidative stress and inflammatory responses [173]. However, some studies have revealed that MCCP50’s inhibition of NLRP3 does not consistently yield renal protective effects in diabetic mice. Instead, it may exacerbate kidney inflammation and damage, including mesangial expansion and glomerulosclerosis [<a href="#CIT0174" class="usa-link" aria-describedby="CIT0174">174</a>]. Therefore, the safety of MCC950 in treating kidney diseases requires further investigation.</p>
<p>CY-09, a novel selective NLRP3 inflammasome inhibitor, binds to the ATP-binding motif of the NACHT domain, inhibits NLRP3 ATPase activity, and blocks inflammation activation. It shows promise in preventing CKD progression. <em>In vitro</em>, CY-09 dose-dependently inhibits NLRP3 inflammasome activation and reduces caspase-1, IL-18, and IL-1β expression, as well as cell apoptosis. In <em>db/db</em> mice, it significantly alleviates DN-induced inflammation, oxidative stress, apoptosis, and fibrosis by inhibiting NLRP3 inflammasome activation [<a href="#CIT0124" class="usa-link" aria-describedby="CIT0124">124</a>]. However, research on CY-09 in the field of CKD remains limited.</p>
<p>Phosphoramidon, an endothelin-converting enzyme inhibitor, may indirectly inhibit NLRP3 inflammasome activation to treat CKD. In a rat CKD model, it protected the kidneys by inhibiting ERS in RTEC and inducing autophagy, suppressing NLRP3 inflammasome activation induced by lipopolysaccharide and ATP, lowering serum creatinine, and alleviating pathological damage such as tubular dilation, glomerular atrophy, and interstitial inflammatory cell infiltration [<a href="#CIT0175" class="usa-link" aria-describedby="CIT0175">175</a>].</p></section><section id="S0008"><h2 class="pmc_sec_title">8. Conclusions</h2>
<p>The NLRP3 inflammasome, a pivotal multi-protein complex in the immune system, has increasingly emerged as a research focus due to its involvement in CKD. Numerous investigations highlight its critical role in initiating and progressing CKD, suggesting its potential as a novel therapeutic target for CKD management. Recent research has explored TCMS for its multi-component, multi-target properties and minimal side effects. This review synthesized evidence from multiple studies, identifying active TCMS compounds—such as astragaloside IV, notoginsenoside, magnolol, pterostilbene, and triptolide—and formulations like Simiao Powder and Bushen Huoxue Prescription—that regulate NLRP3 inflammasome activation to combat CKD. These findings offer valuable insights into the precision clinical application of TCMS in CKD.</p>
<p>Despite the promising research potential of traditional Chinese medicines’ active ingredients, several challenges persist. Current NLRP3-related studies predominantly focus on animal models and <em>in vitro</em> experiments, with a paucity of high-quality clinical trials on TCMS components and formulas. Noteworthy, compounds such as astrgaloside IV and notoginsenoside have exhibited remarkable preclinical efficacy; however, interindividual variability in metabolism and response to TCMS components can lead to inconsistent regulation of NLRP3 inflammasome in certain patients. The absence of compound-specific pharmacokinetic data (e.g., bioavailability, tissue distribution) hinders dose optimization and safety assessment. Additionally, many herbal components suffer from unstable concentrations, low purity, non-standardized extraction processes, poor bioavailability, and unclear mechanisms/safety profiles, limiting clinical translation.The complexity of TCMS composition further poses challenges. TCMS from different regions/batches may vary in constituents, complicating standardization and quality control. In the absence of uniform quality metrics, the efficacy of TCMS remains inconsistent, affecting clinical application. Moreover, the NLRP3 inflammasome activation mechanism is incompletely understood, involving complex crosstalk of multiple signaling pathways that hinder precise regulation. Most studies focus on single pathways, failing to fully reveal traditional Chinese medicine’s multi-target/multi-pathway regulatory effects. Additionally, a lack of validation tools (e.g., gene knockout models, specific antagonists) undermines evidence for TCMS-target specificity.Importantly, given the complex pathophysiology and heterogeneous subtypes of CKD, findings from studies targeting specific kidney diseases cannot extrapolate to all CKD forms. Large-sample, multicenter clinical and experimental studies are urgently needed to validate the efficacy and safety of TCMS components/formulas across CKD subtypes - a critical research priority.</p>
<p>Future research should prioritize multicenter, prospective, stratified randomized controlled trials (stratified by CKD etiology, pathology, and NLRP3 genotype) under TCMS theoretical guidance, exploring the efficacy and safety of TCMS in CKD patients and its mechanisms in regulating NLRP3 inflammasome activation. Technologies like CRISPR-Cas9 should be used to identify TCMS components directly targeting NLRP3, while UPLC-Q-TOF-MS can establish fingerprint maps of NLRP3-regulating TCMS components. <em>In vivo</em> imaging (e.g., two-photon microscopy) may visualize TCMS component distribution in kidneys and colocalization with NLRP3. Constructing a ‘formula-components-targets-pathways’ research framework will analyze synergistic/antagonistic effects of TCMS multi-components on NLRP3 inflammasome. Enhancing TCMS quality control standards and developing targeted delivery systems may increase drug concentration/duration in target organs, improving efficacy. Single-cell sequencing and spatial transcriptomics can reveal key TCMS regulatory targets and inflammatory dynamics across cell types and time points, while reverse validation (e.g., blockers, gene knockout) will clarify mechanisms of TCMS formulas/components in targeting NLRP3 inflammasome. These efforts are essential for advancing CKD-targeted drug development.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by the 2021 Science and Technology Development Programme Project of the Shandong Geriatrics Society (LKJGG2021W113).</p></section><section id="S0010"><h2 class="pmc_sec_title">Disclosure statement</h2>
<p>No potential conflict of interest was reported by the author(s).</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CIT0001">
<span class="label">1.</span><cite>Kalantar-Zadeh K, Jafar TH, Nitsch D, et al. 
Chronic kidney disease. Lancet. 2021;398(10302):786–802. doi: 10.1016/S0140-6736(21)00519-5.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00519-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34175022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Chronic%20kidney%20disease&amp;volume=398&amp;issue=10302&amp;publication_year=2021&amp;pages=786-802&amp;pmid=34175022&amp;doi=10.1016/S0140-6736(21)00519-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0002">
<span class="label">2.</span><cite>Francis A, Harhay MN, Ong ACM, et al. 
Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473–485. doi: 10.1038/s41581-024-00820-6.
</cite> [<a href="https://doi.org/10.1038/s41581-024-00820-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38570631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol&amp;title=Chronic%20kidney%20disease%20and%20the%20global%20public%20health%20agenda:%20an%20international%20consensus&amp;volume=20&amp;issue=7&amp;publication_year=2024&amp;pages=473-485&amp;pmid=38570631&amp;doi=10.1038/s41581-024-00820-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0003">
<span class="label">3.</span><cite>Kalyesubula R, Luyckx VA.. 
Managing risk factors and early intervention for chronic kidney disease. Nat Rev Nephrol. 2025;21(3):149–150. doi: 10.1038/s41581-025-00930-9.
</cite> [<a href="https://doi.org/10.1038/s41581-025-00930-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39814983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol&amp;title=Managing%20risk%20factors%20and%20early%20intervention%20for%20chronic%20kidney%20disease&amp;volume=21&amp;issue=3&amp;publication_year=2025&amp;pages=149-150&amp;pmid=39814983&amp;doi=10.1038/s41581-025-00930-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0004">
<span class="label">4.</span><cite>Wang L, Xu X, Zhang M, et al. 
Prevalence of chronic kidney disease in china: results from the sixth china chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298–310. doi: 10.1001/jamainternmed.2022.6817.
</cite> [<a href="https://doi.org/10.1001/jamainternmed.2022.6817" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9941971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36804760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Intern%20Med&amp;title=Prevalence%20of%20chronic%20kidney%20disease%20in%20china:%20results%20from%20the%20sixth%20china%20chronic%20disease%20and%20risk%20factor%20surveillance&amp;volume=183&amp;issue=4&amp;publication_year=2023&amp;pages=298-310&amp;pmid=36804760&amp;doi=10.1001/jamainternmed.2022.6817&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0005">
<span class="label">5.</span><cite>Lamkanfi M, Dixit VM.. 
The inflammasome turns 15. Nature. 2017;548(7669):534–535. doi: 10.1038/548534a.
</cite> [<a href="https://doi.org/10.1038/548534a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28858314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20inflammasome%20turns%2015&amp;volume=548&amp;issue=7669&amp;publication_year=2017&amp;pages=534-535&amp;pmid=28858314&amp;doi=10.1038/548534a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0006">
<span class="label">6.</span><cite>Sharma BR, Kanneganti T-D.. 
NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550–559. doi: 10.1038/s41590-021-00886-5.
</cite> [<a href="https://doi.org/10.1038/s41590-021-00886-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8132572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33707781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Immunol&amp;title=NLRP3%20inflammasome%20in%20cancer%20and%20metabolic%20diseases&amp;volume=22&amp;issue=5&amp;publication_year=2021&amp;pages=550-559&amp;pmid=33707781&amp;doi=10.1038/s41590-021-00886-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0007">
<span class="label">7.</span><cite>Toldo S, Abbate A.. 
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Nat Rev Cardiol. 2024;21(4):219–237. doi: 10.1038/s41569-023-00946-3.
</cite> [<a href="https://doi.org/10.1038/s41569-023-00946-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11550901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37923829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cardiol&amp;title=The%20role%20of%20the%20NLRP3%20inflammasome%20and%20pyroptosis%20in%20cardiovascular%20diseases&amp;volume=21&amp;issue=4&amp;publication_year=2024&amp;pages=219-237&amp;pmid=37923829&amp;doi=10.1038/s41569-023-00946-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0008">
<span class="label">8.</span><cite>Xu W, Huang Y, Zhou R.. 
NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol. 2025;22(4):341–355. doi: 10.1038/s41423-025-01275-w.
</cite> [<a href="https://doi.org/10.1038/s41423-025-01275-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11955557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40075143/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Mol%20Immunol&amp;title=NLRP3%20inflammasome%20in%20neuroinflammation%20and%20central%20nervous%20system%20diseases&amp;volume=22&amp;issue=4&amp;publication_year=2025&amp;pages=341-355&amp;pmid=40075143&amp;doi=10.1038/s41423-025-01275-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0009">
<span class="label">9.</span><cite>Henedak NT, El-Abhar HS, Soubh AA, et al. 
NLRP3 Inflammasome: a central player in renal pathologies and nephropathy. Life Sci. 2024;351:122813. doi: 10.1016/j.lfs.2024.122813.
</cite> [<a href="https://doi.org/10.1016/j.lfs.2024.122813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38857655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sci&amp;title=NLRP3%20Inflammasome:%20a%20central%20player%20in%20renal%20pathologies%20and%20nephropathy&amp;volume=351&amp;publication_year=2024&amp;pages=122813&amp;pmid=38857655&amp;doi=10.1016/j.lfs.2024.122813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0010">
<span class="label">10.</span><cite>Giuliani KTK, Grivei A, Nag P, et al. 
Hypoxic human proximal tubular epithelial cells undergo ferroptosis and elicit an NLRP3 inflammasome response in CD1c(+) dendritic cells. Cell Death Dis. 2022;13(8):739. doi: 10.1038/s41419-022-05191-z.
</cite> [<a href="https://doi.org/10.1038/s41419-022-05191-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9420140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36030251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Hypoxic%20human%20proximal%20tubular%20epithelial%20cells%20undergo%20ferroptosis%20and%20elicit%20an%20NLRP3%20inflammasome%20response%20in%20CD1c(+)%20dendritic%20cells&amp;volume=13&amp;issue=8&amp;publication_year=2022&amp;pages=739&amp;pmid=36030251&amp;doi=10.1038/s41419-022-05191-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0011">
<span class="label">11.</span><cite>Yong J, Hu H, Zhanjun J, et al. 
Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease. Kidney Dis (Basel). 2024;10(5):369–383. doi: 10.1159/000539496.</cite> [<a href="https://doi.org/10.1159/000539496" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11488838/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39430292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Dis%20(Basel)&amp;title=Therapy%20Targeted%20to%20the%20NLRP3%20Inflammasome%20in%20Chronic%20Kidney%20Disease&amp;publication_year=2024&amp;pmid=39430292&amp;doi=10.1159/000539496&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0012">
<span class="label">12.</span><cite>Jin J, Zhang M. Exploring the role of NLRP3 inflammasome in diabetic nephropathy and the advancements in herbal therapeutics. <em>Front Endocrinol (Lausanne)</em>. 2024;15:1397301. doi: 10.3389/fendo.2024.1397301.</cite> [<a href="https://doi.org/10.3389/fendo.2024.1397301" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11299242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39104818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin%20J,%20Zhang%20M.%20Exploring%20the%20role%20of%20NLRP3%20inflammasome%20in%20diabetic%20nephropathy%20and%20the%20advancements%20in%20herbal%20therapeutics.%20Front%20Endocrinol%20(Lausanne).%202024;15:1397301.%20doi:%2010.3389/fendo.2024.1397301." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0013">
<span class="label">13.</span><cite>Lin L, Pengyu T, Qiming X, et al. 
Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation. Renal Failure. 2024;46(1):2354444. doi: 10.1080/0886022X.2024.2354444.</cite> [<a href="https://doi.org/10.1080/0886022X.2024.2354444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11132749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38785272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Renal%20Failure&amp;title=Bushen%20Huoxue%20formula%20protects%20against%20renal%20fibrosis%20and%20pyroptosis%20in%20chronic%20kidney%20disease%20by%20inhibiting%20ROS/NLRP3-mediated%20inflammasome%20activation&amp;publication_year=2024&amp;pmid=38785272&amp;doi=10.1080/0886022X.2024.2354444&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0014">
<span class="label">14.</span><cite>Hu L, Li L, Che H, et al. 
Huanglian Decoction Treats HenochSchonlein Purpura Nephritis by Inhibiting NF-κB/NLRP3 Signaling Pathway and Reducing Renal IgA Deposition. An Acad Bras Cienc. 2024;96(1):e20220970. doi: 10.1590/0001-3765202420220970.
</cite> [<a href="https://doi.org/10.1590/0001-3765202420220970" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38597498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=An%20Acad%20Bras%20Cienc&amp;title=Huanglian%20Decoction%20Treats%20HenochSchonlein%20Purpura%20Nephritis%20by%20Inhibiting%20NF-%CE%BAB/NLRP3%20Signaling%20Pathway%20and%20Reducing%20Renal%20IgA%20Deposition&amp;volume=96&amp;issue=1&amp;publication_year=2024&amp;pages=e20220970&amp;pmid=38597498&amp;doi=10.1590/0001-3765202420220970&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0015">
<span class="label">15.</span><cite>Wen H, Ting JP, O’Neill LA.. 
A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation?
Nat Immunol. 2012;13(4):352–357. doi: 10.1038/ni.2228.
</cite> [<a href="https://doi.org/10.1038/ni.2228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4090390/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22430788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Immunol&amp;title=A%20role%20for%20the%20NLRP3%20inflammasome%20in%20metabolic%20diseases%E2%80%93did%20Warburg%20miss%20inflammation?&amp;volume=13&amp;issue=4&amp;publication_year=2012&amp;pages=352-357&amp;pmid=22430788&amp;doi=10.1038/ni.2228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0016">
<span class="label">16.</span><cite>Fu J, Wu H.. 
Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41(1):301–316. doi: 10.1146/annurev-immunol-081022-021207.
</cite> [<a href="https://doi.org/10.1146/annurev-immunol-081022-021207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10159982/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36750315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Immunol&amp;title=Structural%20mechanisms%20of%20NLRP3%20inflammasome%20assembly%20and%20activation&amp;volume=41&amp;issue=1&amp;publication_year=2023&amp;pages=301-316&amp;pmid=36750315&amp;doi=10.1146/annurev-immunol-081022-021207&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0017">
<span class="label">17.</span><cite>Lu A, Magupalli VG, Ruan J, et al. 
Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014;156(6):1193–1206. doi: 10.1016/j.cell.2014.02.008.
</cite> [<a href="https://doi.org/10.1016/j.cell.2014.02.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4000066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24630722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Unified%20polymerization%20mechanism%20for%20the%20assembly%20of%20ASC-dependent%20inflammasomes&amp;volume=156&amp;issue=6&amp;publication_year=2014&amp;pages=1193-1206&amp;pmid=24630722&amp;doi=10.1016/j.cell.2014.02.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0018">
<span class="label">18.</span><cite>Martinon F, Burns K, Tschopp J.. 
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417–426. doi: 10.1016/s1097-2765(02)00599-3.
</cite> [<a href="https://doi.org/10.1016/s1097-2765(02)00599-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12191486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell&amp;title=The%20inflammasome:%20a%20molecular%20platform%20triggering%20activation%20of%20inflammatory%20caspases%20and%20processing%20of%20proIL-beta&amp;volume=10&amp;issue=2&amp;publication_year=2002&amp;pages=417-426&amp;pmid=12191486&amp;doi=10.1016/s1097-2765(02)00599-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0019">
<span class="label">19.</span><cite>Wang K, Sun Q, Zhong X, et al. 
Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell. 2020;180(5):941–955.e920. doi: 10.1016/j.cell.2020.02.002.
</cite> [<a href="https://doi.org/10.1016/j.cell.2020.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32109412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Structural%20mechanism%20for%20GSDMD%20targeting%20by%20autoprocessed%20caspases%20in%20pyroptosis&amp;volume=180&amp;issue=5&amp;publication_year=2020&amp;pages=941-955.e920&amp;pmid=32109412&amp;doi=10.1016/j.cell.2020.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0020">
<span class="label">20.</span><cite>Guo H, Callaway JB, Ting JPY.. 
Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687. doi: 10.1038/nm.3893.
</cite> [<a href="https://doi.org/10.1038/nm.3893" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4519035/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26121197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Inflammasomes:%20mechanism%20of%20action,%20role%20in%20disease,%20and%20therapeutics&amp;volume=21&amp;issue=7&amp;publication_year=2015&amp;pages=677-687&amp;pmid=26121197&amp;doi=10.1038/nm.3893&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0021">
<span class="label">21.</span><cite>Malik A, Kanneganti TD.. 
Inflammasome activation and assembly at a glance. J Cell Sci. 2017;130(23):3955–3963. doi: 10.1242/jcs.207365.
</cite> [<a href="https://doi.org/10.1242/jcs.207365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5769591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29196474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Sci&amp;title=Inflammasome%20activation%20and%20assembly%20at%20a%20glance&amp;volume=130&amp;issue=23&amp;publication_year=2017&amp;pages=3955-3963&amp;pmid=29196474&amp;doi=10.1242/jcs.207365&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0022">
<span class="label">22.</span><cite>Swanson KV, Deng M, Ting JP.. 
The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi: 10.1038/s41577-019-0165-0.
</cite> [<a href="https://doi.org/10.1038/s41577-019-0165-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7807242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31036962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=The%20NLRP3%20inflammasome:%20molecular%20activation%20and%20regulation%20to%20therapeutics&amp;volume=19&amp;issue=8&amp;publication_year=2019&amp;pages=477-489&amp;pmid=31036962&amp;doi=10.1038/s41577-019-0165-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0023">
<span class="label">23.</span><cite>Kodi T, Sankhe R, Gopinathan A, et al. 
New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation. J Neuroimmune Pharmacol. 2024;19(1):7. doi: 10.1007/s11481-024-10101-5.
</cite> [<a href="https://doi.org/10.1007/s11481-024-10101-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10904444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38421496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuroimmune%20Pharmacol&amp;title=New%20insights%20on%20NLRP3%20inflammasome:%20mechanisms%20of%20activation,%20inhibition,%20and%20epigenetic%20regulation&amp;volume=19&amp;issue=1&amp;publication_year=2024&amp;pages=7&amp;pmid=38421496&amp;doi=10.1007/s11481-024-10101-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0024">
<span class="label">24.</span><cite>Xu J, Núñez G.. 
The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci. 2023;48(4):331–344. doi: 10.1016/j.tibs.2022.10.002.
</cite> [<a href="https://doi.org/10.1016/j.tibs.2022.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10023278/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36336552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Biochem%20Sci&amp;title=The%20NLRP3%20inflammasome:%20activation%20and%20regulation&amp;volume=48&amp;issue=4&amp;publication_year=2023&amp;pages=331-344&amp;pmid=36336552&amp;doi=10.1016/j.tibs.2022.10.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0025">
<span class="label">25.</span><cite>Gong T, Liu L, Jiang W, et al. 
DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20(2):95–112. doi: 10.1038/s41577-019-0215-7.
</cite> [<a href="https://doi.org/10.1038/s41577-019-0215-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31558839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=DAMP-sensing%20receptors%20in%20sterile%20inflammation%20and%20inflammatory%20diseases&amp;volume=20&amp;issue=2&amp;publication_year=2020&amp;pages=95-112&amp;pmid=31558839&amp;doi=10.1038/s41577-019-0215-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0026">
<span class="label">26.</span><cite>Nagar A, Bharadwaj R, Shaikh MOF, et al. 
What are NLRP3-ASC specks? an experimental progress of 22 years of inflammasome research. Front Immunol. 2023;14:1188864. volume2023. doi: 10.3389/fimmu.2023.1188864.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1188864" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10411722/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37564644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=What%20are%20NLRP3-ASC%20specks?%20an%20experimental%20progress%20of%2022%20years%20of%20inflammasome%20research&amp;volume=14&amp;publication_year=2023&amp;pages=1188864&amp;pmid=37564644&amp;doi=10.3389/fimmu.2023.1188864&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0027">
<span class="label">27.</span><cite>Zheng R, Yan Y, Dai S, et al. 
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities. J Neuroinflammation. 2023;20(1):26. doi: 10.1186/s12974-023-02709-w.
</cite> [<a href="https://doi.org/10.1186/s12974-023-02709-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9899382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36740674/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuroinflammation&amp;title=ASC%20specks%20exacerbate%20%CE%B1%E2%80%91synuclein%20pathology%20via%20amplifying%20NLRP3%20inflammasome%20activities&amp;volume=20&amp;issue=1&amp;publication_year=2023&amp;pages=26&amp;pmid=36740674&amp;doi=10.1186/s12974-023-02709-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0028">
<span class="label">28.</span><cite>Dinarello CA.
The C3a receptor, caspase-1, and release of IL-1β. Blood. 2013;122(20):3394–3395. doi: 10.1182/blood-2013-08-518282.
</cite> [<a href="https://doi.org/10.1182/blood-2013-08-518282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3829112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24235127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=The%20C3a%20receptor,%20caspase-1,%20and%20release%20of%20IL-1%CE%B2&amp;volume=122&amp;issue=20&amp;publication_year=2013&amp;pages=3394-3395&amp;pmid=24235127&amp;doi=10.1182/blood-2013-08-518282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0029">
<span class="label">29.</span><cite>Huang Y, Xu W, Zhou R.. 
NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114–2127. doi: 10.1038/s41423-021-00740-6.
</cite> [<a href="https://doi.org/10.1038/s41423-021-00740-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8429580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34321623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Mol%20Immunol&amp;title=NLRP3%20inflammasome%20activation%20and%20cell%20death&amp;volume=18&amp;issue=9&amp;publication_year=2021&amp;pages=2114-2127&amp;pmid=34321623&amp;doi=10.1038/s41423-021-00740-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0030">
<span class="label">30.</span><cite>Liu Z, Wang C, Yang J, et al. 
Caspase-1 engages full-length gasdermin D through two distinct interfaces that mediate caspase recruitment and substrate cleavage. Immunity. 2020;53(1):106–114.e5. e105. doi: 10.1016/j.immuni.2020.06.007.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2020.06.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7382298/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32553275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Caspase-1%20engages%20full-length%20gasdermin%20D%20through%20two%20distinct%20interfaces%20that%20mediate%20caspase%20recruitment%20and%20substrate%20cleavage&amp;volume=53&amp;issue=1&amp;publication_year=2020&amp;pages=106-114.e5&amp;pmid=32553275&amp;doi=10.1016/j.immuni.2020.06.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0031">
<span class="label">31.</span><cite>ChangYan L, Chen G, JiangMing W, et al. 
Investigating the inflammatory mechanism of notoginsenoside R1 in Diabetic nephropathy via ITGB8 based on network pharmacology and experimental validation. Mol Med. 2024;30(1):277. doi: 10.1186/s10020-024-01055-8.</cite> [<a href="https://doi.org/10.1186/s10020-024-01055-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11674371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39725889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Med&amp;title=Investigating%20the%20inflammatory%20mechanism%20of%20notoginsenoside%20R1%20in%20Diabetic%20nephropathy%20via%20ITGB8%20based%20on%20network%20pharmacology%20and%20experimental%20validation&amp;publication_year=2024&amp;pmid=39725889&amp;doi=10.1186/s10020-024-01055-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0032">
<span class="label">32.</span><cite>Shahzad K, Fatima S, Khawaja H, et al. 
Podocyte-specific NLRP3 inflammasome activation promotes diabetic kidney disease. Kidney Int. 2022;102(4):766–779. doi: 10.1016/j.kint.2022.06.010.
</cite> [<a href="https://doi.org/10.1016/j.kint.2022.06.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35779608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Podocyte-specific%20NLRP3%20inflammasome%20activation%20promotes%20diabetic%20kidney%20disease&amp;volume=102&amp;issue=4&amp;publication_year=2022&amp;pages=766-779&amp;pmid=35779608&amp;doi=10.1016/j.kint.2022.06.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0033">
<span class="label">33.</span><cite>Zamyatina A, Heine H.. 
Corrigendum: lipopolysaccharide Recognition in the crossroads of TLR4 and Caspase-4/11 mediated inflammatory pathways. Front Immunol. 2021;12:649442. doi: 10.3389/fimmu.2021.649442.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.649442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7876549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33584736/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Corrigendum:%20lipopolysaccharide%20Recognition%20in%20the%20crossroads%20of%20TLR4%20and%20Caspase-4/11%20mediated%20inflammatory%20pathways&amp;volume=12&amp;publication_year=2021&amp;pages=649442&amp;pmid=33584736&amp;doi=10.3389/fimmu.2021.649442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0034">
<span class="label">34.</span><cite>Zhu F, Ma J, Li W, et al. 
The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome. Immunity. 2023;56(4):753–767.e758. doi: 10.1016/j.immuni.2023.03.003.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2023.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37001519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=The%20orphan%20receptor%20Nur77%20binds%20cytoplasmic%20LPS%20to%20activate%20the%20non-canonical%20NLRP3%20inflammasome&amp;volume=56&amp;issue=4&amp;publication_year=2023&amp;pages=753-767.e758&amp;pmid=37001519&amp;doi=10.1016/j.immuni.2023.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0035">
<span class="label">35.</span><cite>Orzalli MH.
An orphan no more: nur77 senses cytosolic LPS. Immunity. 2023;56(4):742–744. doi: 10.1016/j.immuni.2023.03.012.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2023.03.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37044063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=An%20orphan%20no%20more:%20nur77%20senses%20cytosolic%20LPS&amp;volume=56&amp;issue=4&amp;publication_year=2023&amp;pages=742-744&amp;pmid=37044063&amp;doi=10.1016/j.immuni.2023.03.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0036">
<span class="label">36.</span><cite>Kang S, Fernandes-Alnemri T, Rogers C, et al. 
Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat Commun. 2015;6(1):7515. doi: 10.1038/ncomms8515.
</cite> [<a href="https://doi.org/10.1038/ncomms8515" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4480782/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26104484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Caspase-8%20scaffolding%20function%20and%20MLKL%20regulate%20NLRP3%20inflammasome%20activation%20downstream%20of%20TLR3&amp;volume=6&amp;issue=1&amp;publication_year=2015&amp;pages=7515&amp;pmid=26104484&amp;doi=10.1038/ncomms8515&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0037">
<span class="label">37.</span><cite>Chung H, Vilaysane A, Lau A, et al. 
NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis. Cell Death Differ. 2016;23(8):1331–1346. doi: 10.1038/cdd.2016.14.
</cite> [<a href="https://doi.org/10.1038/cdd.2016.14" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4947664/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26891693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Differ&amp;title=NLRP3%20regulates%20a%20non-canonical%20platform%20for%20caspase-8%20activation%20during%20epithelial%20cell%20apoptosis&amp;volume=23&amp;issue=8&amp;publication_year=2016&amp;pages=1331-1346&amp;pmid=26891693&amp;doi=10.1038/cdd.2016.14&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0038">
<span class="label">38.</span><cite>Zheng M, Kanneganti TD.. 
The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297(1):26–38. doi: 10.1111/imr.12909.
</cite> [<a href="https://doi.org/10.1111/imr.12909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7811275/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32729116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunol%20Rev&amp;title=The%20regulation%20of%20the%20ZBP1-NLRP3%20inflammasome%20and%20its%20implications%20in%20pyroptosis,%20apoptosis,%20and%20necroptosis%20(PANoptosis)&amp;volume=297&amp;issue=1&amp;publication_year=2020&amp;pages=26-38&amp;pmid=32729116&amp;doi=10.1111/imr.12909&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0039">
<span class="label">39.</span><cite>Gong T, Yang Y, Jin T, et al. 
Orchestration of NLRP3 inflammasome activation by ion fluxes. Trends Immunol. 2018;39(5):393–406. doi: 10.1016/j.it.2018.01.009.
</cite> [<a href="https://doi.org/10.1016/j.it.2018.01.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29452983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Immunol&amp;title=Orchestration%20of%20NLRP3%20inflammasome%20activation%20by%20ion%20fluxes&amp;volume=39&amp;issue=5&amp;publication_year=2018&amp;pages=393-406&amp;pmid=29452983&amp;doi=10.1016/j.it.2018.01.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0040">
<span class="label">40.</span><cite>Han Y, Xu X, Tang C, et al. 
ROS promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-<em>TXNIP</em>-NLRP3 biological axis. Redox Biol. 2018;16:32–46. doi: 10.1016/j.redox.2018.02.013.
</cite> [<a href="https://doi.org/10.1016/j.redox.2018.02.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5842313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29475133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Redox%20Biol&amp;title=ROS%20promote%20tubular%20injury%20in%20diabetic%20nephropathy:%20the%20role%20of%20the%20mitochondrial%20ros-TXNIP-NLRP3%20biological%20axis&amp;volume=16&amp;publication_year=2018&amp;pages=32-46&amp;pmid=29475133&amp;doi=10.1016/j.redox.2018.02.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0041">
<span class="label">41.</span><cite>Zhou Y, Tong Z, Jiang S, et al. 
The roles of endoplasmic reticulum in NLRP3 inflammasome Activation. Cells. 2020;9(5):1219. doi: 10.3390/cells9051219.
</cite> [<a href="https://doi.org/10.3390/cells9051219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7291288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32423023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=The%20roles%20of%20endoplasmic%20reticulum%20in%20NLRP3%20inflammasome%20Activation&amp;volume=9&amp;issue=5&amp;publication_year=2020&amp;pages=1219&amp;pmid=32423023&amp;doi=10.3390/cells9051219&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0042">
<span class="label">42.</span><cite>Li Z, Yao Y-X, Lu X, et al. 
Short-term respiratory cadmium exposure partially activates pulmonary NLRP3 inflammasome by inducing ferroptosis in mice. Ecotoxicol Environ Saf. 2024;285:117106. doi: 10.1016/j.ecoenv.2024.117106.
</cite> [<a href="https://doi.org/10.1016/j.ecoenv.2024.117106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39326353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ecotoxicol%20Environ%20Saf&amp;title=Short-term%20respiratory%20cadmium%20exposure%20partially%20activates%20pulmonary%20NLRP3%20inflammasome%20by%20inducing%20ferroptosis%20in%20mice&amp;volume=285&amp;publication_year=2024&amp;pages=117106&amp;pmid=39326353&amp;doi=10.1016/j.ecoenv.2024.117106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0043">
<span class="label">43.</span><cite>Malireddi RKS, Bynigeri RR, Mall R, et al. 
Whole-genome CRISPR screen identifies RAVER1 as a key regulator of RIPK1-mediated inflammatory cell death, PANoptosis. iScience. 2023;26(6):106938. doi: 10.1016/j.isci.2023.106938.
</cite> [<a href="https://doi.org/10.1016/j.isci.2023.106938" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10265528/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37324531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=iScience&amp;title=Whole-genome%20CRISPR%20screen%20identifies%20RAVER1%20as%20a%20key%20regulator%20of%20RIPK1-mediated%20inflammatory%20cell%20death,%20PANoptosis&amp;volume=26&amp;issue=6&amp;publication_year=2023&amp;pages=106938&amp;pmid=37324531&amp;doi=10.1016/j.isci.2023.106938&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0044">
<span class="label">44.</span><cite>Zhou X, Ji S, Chen L, et al. 
Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome. Microbiome. 2024;12(1):109. doi: 10.1186/s40168-024-01826-9.
</cite> [<a href="https://doi.org/10.1186/s40168-024-01826-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11191305/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38907332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Microbiome&amp;title=Gut%20microbiota%20dysbiosis%20in%20hyperuricaemia%20promotes%20renal%20injury%20through%20the%20activation%20of%20NLRP3%20inflammasome&amp;volume=12&amp;issue=1&amp;publication_year=2024&amp;pages=109&amp;pmid=38907332&amp;doi=10.1186/s40168-024-01826-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0045">
<span class="label">45.</span><cite>Muñoz-Planillo R, Kuffa P, Martínez-Colón G, et al. 
Is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38(6):1142–1153. <sup>+</sup> doi: 10.1016/j.immuni.2013.05.016.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2013.05.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3730833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23809161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Is%20the%20common%20trigger%20of%20NLRP3%20inflammasome%20activation%20by%20bacterial%20toxins%20and%20particulate%20matter&amp;volume=38&amp;issue=6&amp;publication_year=2013&amp;pages=1142-1153&amp;pmid=23809161&amp;doi=10.1016/j.immuni.2013.05.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0046">
<span class="label">46.</span><cite>Seoane PI, Beswick JA, Leach AG, et al. 
Squaramides enhance NLRP3 inflammasome activation by lowering intracellular potassium. Cell Death Discov. 2023;9(1):469. doi: 10.1038/s41420-023-01756-9.
</cite> [<a href="https://doi.org/10.1038/s41420-023-01756-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10739973/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38129373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Discov&amp;title=Squaramides%20enhance%20NLRP3%20inflammasome%20activation%20by%20lowering%20intracellular%20potassium&amp;volume=9&amp;issue=1&amp;publication_year=2023&amp;pages=469&amp;pmid=38129373&amp;doi=10.1038/s41420-023-01756-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0047">
<span class="label">47.</span><cite>He Y, Zeng MY, Yang D, et al. 
<em>NEK7</em> is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530(7590):354–357. doi: 10.1038/nature16959.
</cite> [<a href="https://doi.org/10.1038/nature16959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4810788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26814970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=NEK7%20is%20an%20essential%20mediator%20of%20NLRP3%20activation%20downstream%20of%20potassium%20efflux&amp;volume=530&amp;issue=7590&amp;publication_year=2016&amp;pages=354-357&amp;pmid=26814970&amp;doi=10.1038/nature16959&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0048">
<span class="label">48.</span><cite>Sharif H, Wang L, Wang WL, et al. 
Structural mechanism for <em>NEK7</em>-licensed activation of NLRP3 inflammasome. Nature. 2019;570(7761):338–343. doi: 10.1038/s41586-019-1295-z.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1295-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6774351/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31189953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structural%20mechanism%20for%20NEK7-licensed%20activation%20of%20NLRP3%20inflammasome&amp;volume=570&amp;issue=7761&amp;publication_year=2019&amp;pages=338-343&amp;pmid=31189953&amp;doi=10.1038/s41586-019-1295-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0049">
<span class="label">49.</span><cite>Xu J, Zhang L, Duan Y, et al. 
<em>NEK7</em> phosphorylation amplifies NLRP3 inflammasome activation downstream of potassium efflux and gasdermin D. Sci Immunol. 2025;10(103):eadl2993. doi: 10.1126/sciimmunol.adl2993.
</cite> [<a href="https://doi.org/10.1126/sciimmunol.adl2993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12020992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39752537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Immunol&amp;title=NEK7%20phosphorylation%20amplifies%20NLRP3%20inflammasome%20activation%20downstream%20of%20potassium%20efflux%20and%20gasdermin%20D&amp;volume=10&amp;issue=103&amp;publication_year=2025&amp;pages=eadl2993&amp;pmid=39752537&amp;doi=10.1126/sciimmunol.adl2993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0050">
<span class="label">50.</span><cite>Martín-Sánchez F, Compan V, Peñín-Franch A, et al. 
ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux. Journal of Cell Biology. 2023;222(8):e202003053. doi: 10.1083/jcb.202003053.
</cite> [<a href="https://doi.org/10.1083/jcb.202003053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10318405/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37402211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cell%20Biology&amp;title=ASC%20oligomer%20favors%20caspase-1CARD%20domain%20recruitment%20after%20intracellular%20potassium%20efflux&amp;volume=222&amp;issue=8&amp;publication_year=2023&amp;pages=e202003053&amp;pmid=37402211&amp;doi=10.1083/jcb.202003053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0051">
<span class="label">51.</span><cite>Groß CJ, Mishra R, Schneider KS, et al. 
K(+) efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity. 2016;45(4):761–773. doi: 10.1016/j.immuni.2016.08.010.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2016.08.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27692612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=K(+)%20efflux-independent%20NLRP3%20inflammasome%20activation%20by%20small%20molecules%20targeting%20mitochondria&amp;volume=45&amp;issue=4&amp;publication_year=2016&amp;pages=761-773&amp;pmid=27692612&amp;doi=10.1016/j.immuni.2016.08.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0052">
<span class="label">52.</span><cite>Holley CL, Emming S, Monteleone MM, et al. 
The septin modifier, forchlorfenuron, activates NLRP3 via a potassium-independent mitochondrial axis. Cell Chem Biol. 2024;31(5):962–972.e4. e964. doi: 10.1016/j.chembiol.2024.04.012.
</cite> [<a href="https://doi.org/10.1016/j.chembiol.2024.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38759620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Chem%20Biol&amp;title=The%20septin%20modifier,%20forchlorfenuron,%20activates%20NLRP3%20via%20a%20potassium-independent%20mitochondrial%20axis&amp;volume=31&amp;issue=5&amp;publication_year=2024&amp;pages=962-972.e4&amp;pmid=38759620&amp;doi=10.1016/j.chembiol.2024.04.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0053">
<span class="label">53.</span><cite>He X, Peng Y, Huang S, et al. 
Blood brain barrier-crossing delivery of felodipine nanodrug ameliorates anxiety-like behavior and cognitive impairment in Alzheimer’s disease. Adv Sci. 2024;11(34):2401731. doi: 10.1002/advs.202401731.</cite> [<a href="https://doi.org/10.1002/advs.202401731" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11425895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38981028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Sci&amp;title=Blood%20brain%20barrier-crossing%20delivery%20of%20felodipine%20nanodrug%20ameliorates%20anxiety-like%20behavior%20and%20cognitive%20impairment%20in%20Alzheimer%E2%80%99s%20disease&amp;volume=11&amp;issue=34&amp;publication_year=2024&amp;pages=2401731&amp;pmid=38981028&amp;doi=10.1002/advs.202401731&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0054">
<span class="label">54.</span><cite>Jäger E, Murthy S, Schmidt C, et al. 
Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis. Nat Commun. 2020;11(1):4243. doi: 10.1038/s41467-020-17749-6.
</cite> [<a href="https://doi.org/10.1038/s41467-020-17749-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7447633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32843625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Calcium-sensing%20receptor-mediated%20NLRP3%20inflammasome%20response%20to%20calciprotein%20particles%20drives%20inflammation%20in%20rheumatoid%20arthritis&amp;volume=11&amp;issue=1&amp;publication_year=2020&amp;pages=4243&amp;pmid=32843625&amp;doi=10.1038/s41467-020-17749-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0055">
<span class="label">55.</span><cite>Murakami T, Ockinger J, Yu J, et al. 
Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A. 2012;109(28):11282–11287. doi: 10.1073/pnas.1117765109.
</cite> [<a href="https://doi.org/10.1073/pnas.1117765109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3396518/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22733741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Critical%20role%20for%20calcium%20mobilization%20in%20activation%20of%20the%20NLRP3%20inflammasome&amp;volume=109&amp;issue=28&amp;publication_year=2012&amp;pages=11282-11287&amp;pmid=22733741&amp;doi=10.1073/pnas.1117765109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0056">
<span class="label">56.</span><cite>Kang H, Choi SW, Kim JY, et al. 
ER-to-lysosome Ca(2+) refilling followed by K(+) efflux-coupled store-operated Ca(2+) entry in inflammasome activation and metabolic inflammation. Elife. 2024;12:RP87561. doi: 10.7554/eLife.87561.</cite> [<a href="https://doi.org/10.7554/eLife.87561" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11219040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38953285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=ER-to-lysosome%20Ca(2+)%20refilling%20followed%20by%20K(+)%20efflux-coupled%20store-operated%20Ca(2+)%20entry%20in%20inflammasome%20activation%20and%20metabolic%20inflammation&amp;volume=12&amp;publication_year=2024&amp;pmid=38953285&amp;doi=10.7554/eLife.87561&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0057">
<span class="label">57.</span><cite>Kendall RL, Holian A.. 
Lysosomal BK channels facilitate silica-induced inflammation in macrophages. Inhal Toxicol. 2024;36(1):31–43. doi: 10.1080/08958378.2024.2305112.
</cite> [<a href="https://doi.org/10.1080/08958378.2024.2305112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11080613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38261520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inhal%20Toxicol&amp;title=Lysosomal%20BK%20channels%20facilitate%20silica-induced%20inflammation%20in%20macrophages&amp;volume=36&amp;issue=1&amp;publication_year=2024&amp;pages=31-43&amp;pmid=38261520&amp;doi=10.1080/08958378.2024.2305112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0058">
<span class="label">58.</span><cite>Ran L, Ye T, Erbs E, et al. 
KCNN4 links PIEZO-dependent mechanotransduction to NLRP3 inflammasome activation. Sci Immunol. 2023;8(90):eadf4699. doi: 10.1126/sciimmunol.adf4699.
</cite> [<a href="https://doi.org/10.1126/sciimmunol.adf4699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38134241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Immunol&amp;title=KCNN4%20links%20PIEZO-dependent%20mechanotransduction%20to%20NLRP3%20inflammasome%20activation&amp;volume=8&amp;issue=90&amp;publication_year=2023&amp;pages=eadf4699&amp;pmid=38134241&amp;doi=10.1126/sciimmunol.adf4699&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0059">
<span class="label">59.</span><cite>Katsnelson MA, Rucker LG, Russo HM, et al. 
K<sup>+</sup> efflux agonists induce NLRP3 inflammasome activation independently of Ca<sup>2+</sup> signaling. J Immunol. 2015;194(8):3937–3952. doi: 10.4049/jimmunol.1402658.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1402658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4390495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25762778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol&amp;title=K+%20efflux%20agonists%20induce%20NLRP3%20inflammasome%20activation%20independently%20of%20Ca2+%20signaling&amp;volume=194&amp;issue=8&amp;publication_year=2015&amp;pages=3937-3952&amp;pmid=25762778&amp;doi=10.4049/jimmunol.1402658&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0060">
<span class="label">60.</span><cite>Hsueh-Hsiao W, Hsin-Chung C-RH, Hsin-An L, et al. 
Magnesium-enriched deep-sea water inhibits NLRP3 inflammasome activation and dampens inflammation. Heliyon. 2024;10(15):e35136. doi: 10.1016/j.heliyon.2024.e35136.</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e35136" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11327587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39157306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=Magnesium-enriched%20deep-sea%20water%20inhibits%20NLRP3%20inflammasome%20activation%20and%20dampens%20inflammation&amp;publication_year=2024&amp;pmid=39157306&amp;doi=10.1016/j.heliyon.2024.e35136&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0061">
<span class="label">61.</span><cite>Li C, Chen M, He X, et al. 
A mini-review on ion fluxes that regulate NLRP3 inflammasome activation. Acta Biochim Biophys Sin (Shanghai). 2021;53(2):131–139. doi: 10.1093/abbs/gmaa155.
</cite> [<a href="https://doi.org/10.1093/abbs/gmaa155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33355638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Biochim%20Biophys%20Sin%20(Shanghai)&amp;title=A%20mini-review%20on%20ion%20fluxes%20that%20regulate%20NLRP3%20inflammasome%20activation&amp;volume=53&amp;issue=2&amp;publication_year=2021&amp;pages=131-139&amp;pmid=33355638&amp;doi=10.1093/abbs/gmaa155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0062">
<span class="label">62.</span><cite>Pitzer A, Elijovich F, Laffer CL, et al. 
DC ENaC-dependent inflammasome activation contributes to salt-sensitive hypertension. Circ Res. 2022;131(4):328–344. doi: 10.1161/CIRCRESAHA.122.320818.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.122.320818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9357159/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35862128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ%20Res&amp;title=DC%20ENaC-dependent%20inflammasome%20activation%20contributes%20to%20salt-sensitive%20hypertension&amp;volume=131&amp;issue=4&amp;publication_year=2022&amp;pages=328-344&amp;pmid=35862128&amp;doi=10.1161/CIRCRESAHA.122.320818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0063">
<span class="label">63.</span><cite>Tang T, Lang X, Xu C, et al. 
CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat Commun. 2017;8(1):202. doi: 10.1038/s41467-017-00227-x.
</cite> [<a href="https://doi.org/10.1038/s41467-017-00227-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5544706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28779175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=CLICs-dependent%20chloride%20efflux%20is%20an%20essential%20and%20proximal%20upstream%20event%20for%20NLRP3%20inflammasome%20activation&amp;volume=8&amp;issue=1&amp;publication_year=2017&amp;pages=202&amp;pmid=28779175&amp;doi=10.1038/s41467-017-00227-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0064">
<span class="label">64.</span><cite>Galvan DL, Green NH, Danesh FR.. 
The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. 2017;92(5):1051–1057. doi: 10.1016/j.kint.2017.05.034.
</cite> [<a href="https://doi.org/10.1016/j.kint.2017.05.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5667560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28893420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=The%20hallmarks%20of%20mitochondrial%20dysfunction%20in%20chronic%20kidney%20disease&amp;volume=92&amp;issue=5&amp;publication_year=2017&amp;pages=1051-1057&amp;pmid=28893420&amp;doi=10.1016/j.kint.2017.05.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0065">
<span class="label">65.</span><cite>Tang C, Cai J, Yin XM, et al. 
Mitochondrial quality control in kidney injury and repair. Nat Rev Nephrol. 2021;17(5):299–318. doi: 10.1038/s41581-020-00369-0.
</cite> [<a href="https://doi.org/10.1038/s41581-020-00369-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8958893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33235391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol&amp;title=Mitochondrial%20quality%20control%20in%20kidney%20injury%20and%20repair&amp;volume=17&amp;issue=5&amp;publication_year=2021&amp;pages=299-318&amp;pmid=33235391&amp;doi=10.1038/s41581-020-00369-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0066">
<span class="label">66.</span><cite>Hsu W-H, Hua K-F, Tuan L-H, et al. 
Compound K inhibits priming and mitochondria-associated activating signals of NLRP3 inflammasome in renal tubulointerstitial lesions. Nephrology Dialysis Transplantation. 2020;35(1):74–85.</cite> [<a href="https://doi.org/10.1093/ndt/gfz073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31065699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrology%20Dialysis%20Transplantation&amp;title=Compound%20K%20inhibits%20priming%20and%20mitochondria-associated%20activating%20signals%20of%20NLRP3%20inflammasome%20in%20renal%20tubulointerstitial%20lesions&amp;volume=35&amp;issue=1&amp;publication_year=2020&amp;pages=74-85&amp;pmid=31065699&amp;doi=10.1093/ndt/gfz073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0067">
<span class="label">67.</span><cite>Zhou R, Yazdi AS, Menu P, et al. 
A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221–225. doi: 10.1038/nature09663.
</cite> [<a href="https://doi.org/10.1038/nature09663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21124315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A%20role%20for%20mitochondria%20in%20NLRP3%20inflammasome%20activation&amp;volume=469&amp;issue=7329&amp;publication_year=2011&amp;pages=221-225&amp;pmid=21124315&amp;doi=10.1038/nature09663&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0068">
<span class="label">68.</span><cite>Nam BY, Jhee JH, Park J, et al. 
PGC-1α inhibits the NLRP3 inflammasome via preserving mitochondrial viability to protect kidney fibrosis. Cell Death Dis. 2022;13(1):31. doi: 10.1038/s41419-021-04480-3.
</cite> [<a href="https://doi.org/10.1038/s41419-021-04480-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8748677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35013155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=PGC-1%CE%B1%20inhibits%20the%20NLRP3%20inflammasome%20via%20preserving%20mitochondrial%20viability%20to%20protect%20kidney%20fibrosis&amp;volume=13&amp;issue=1&amp;publication_year=2022&amp;pages=31&amp;pmid=35013155&amp;doi=10.1038/s41419-021-04480-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0069">
<span class="label">69.</span><cite>Billingham LK, Stoolman JS, Vasan K, et al. 
Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nat Immunol. 2022;23(5):692–704. doi: 10.1038/s41590-022-01185-3.
</cite> [<a href="https://doi.org/10.1038/s41590-022-01185-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9098388/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35484407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Immunol&amp;title=Mitochondrial%20electron%20transport%20chain%20is%20necessary%20for%20NLRP3%20inflammasome%20activation&amp;volume=23&amp;issue=5&amp;publication_year=2022&amp;pages=692-704&amp;pmid=35484407&amp;doi=10.1038/s41590-022-01185-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0070">
<span class="label">70.</span><cite>Choi E-H, Park S-J.. 
<em>TXNIP</em>: a key protein in the cellular stress response pathway and a potential therapeutic target. Exp Mol Med. 2023;55(7):1348–1356. doi: 10.1038/s12276-023-01019-8.
</cite> [<a href="https://doi.org/10.1038/s12276-023-01019-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10393958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37394581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Mol%20Med&amp;title=TXNIP:%20a%20key%20protein%20in%20the%20cellular%20stress%20response%20pathway%20and%20a%20potential%20therapeutic%20target&amp;volume=55&amp;issue=7&amp;publication_year=2023&amp;pages=1348-1356&amp;pmid=37394581&amp;doi=10.1038/s12276-023-01019-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0071">
<span class="label">71.</span><cite>Fatma E, George SGS, Eman M-K, et al. 
Diltiazem mitigates acute liver injury by targeting NFκB-<em>TXNIP</em>/NLRP3 axis in Rats: new insights beyond calcium channel blockade. Int Immunopharmacol. 2024;143(Pt 2):113460. doi: 10.1016/j.intimp.2024.113460.</cite> [<a href="https://doi.org/10.1016/j.intimp.2024.113460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39514911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Immunopharmacol&amp;title=Diltiazem%20mitigates%20acute%20liver%20injury%20by%20targeting%20NF%CE%BAB-TXNIP/NLRP3%20axis%20in%20Rats:%20new%20insights%20beyond%20calcium%20channel%20blockade&amp;publication_year=2024&amp;pmid=39514911&amp;doi=10.1016/j.intimp.2024.113460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0072">
<span class="label">72.</span><cite>Pan M, Zhang F, Qu K, et al. 
<em>TXNIP</em>: a double-edged sword in disease and therapeutic outlook. Oxid Med Cell Longev. 2022;2022(1):7805115. doi: 10.1155/2022/7805115.
</cite> [<a href="https://doi.org/10.1155/2022/7805115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9017576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35450411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oxid%20Med%20Cell%20Longev&amp;title=TXNIP:%20a%20double-edged%20sword%20in%20disease%20and%20therapeutic%20outlook&amp;volume=2022&amp;issue=1&amp;publication_year=2022&amp;pages=7805115&amp;pmid=35450411&amp;doi=10.1155/2022/7805115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0073">
<span class="label">73.</span><cite>Zhou R, Tardivel A, Thorens B, et al. 
Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi: 10.1038/ni.1831.
</cite> [<a href="https://doi.org/10.1038/ni.1831" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20023662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Immunol&amp;title=Thioredoxin-interacting%20protein%20links%20oxidative%20stress%20to%20inflammasome%20activation&amp;volume=11&amp;issue=2&amp;publication_year=2010&amp;pages=136-140&amp;pmid=20023662&amp;doi=10.1038/ni.1831&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0074">
<span class="label">74.</span><cite>Dai X, Liao R, Liu C, et al. 
Epigenetic regulation of <em>TXNIP</em>-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol. 2021;45:102033. doi: 10.1016/j.redox.2021.102033.
</cite> [<a href="https://doi.org/10.1016/j.redox.2021.102033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8209273/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34119876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Redox%20Biol&amp;title=Epigenetic%20regulation%20of%20TXNIP-mediated%20oxidative%20stress%20and%20NLRP3%20inflammasome%20activation%20contributes%20to%20SAHH%20inhibition-aggravated%20diabetic%20nephropathy&amp;volume=45&amp;publication_year=2021&amp;pages=102033&amp;pmid=34119876&amp;doi=10.1016/j.redox.2021.102033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0075">
<span class="label">75.</span><cite>Wen Y, Liu Y-R, Tang T-T, et al. 
mROS-<em>TXNIP</em> axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI. Int J Biochem Cell Biol. 2018;98:43–53. doi: 10.1016/j.biocel.2018.02.015.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2018.02.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29477360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Biochem%20Cell%20Biol&amp;title=mROS-TXNIP%20axis%20activates%20NLRP3%20inflammasome%20to%20mediate%20renal%20injury%20during%20ischemic%20AKI&amp;volume=98&amp;publication_year=2018&amp;pages=43-53&amp;pmid=29477360&amp;doi=10.1016/j.biocel.2018.02.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0076">
<span class="label">76.</span><cite>Abais JM, Xia M, Li G, et al. 
Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via Thioredoxin-Interacting Protein (<em>TXNIP</em>) during hyperhomocysteinemia. J Biol Chem. 2014;289(39):27159–27168. * doi: 10.1074/jbc.M114.567537.
</cite> [<a href="https://doi.org/10.1074/jbc.M114.567537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4175351/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25138219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=Nod-like%20receptor%20protein%203%20(NLRP3)%20inflammasome%20activation%20and%20podocyte%20injury%20via%20Thioredoxin-Interacting%20Protein%20(TXNIP)%20during%20hyperhomocysteinemia&amp;volume=289&amp;issue=39&amp;publication_year=2014&amp;pages=27159-27168&amp;pmid=25138219&amp;doi=10.1074/jbc.M114.567537&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0077">
<span class="label">77.</span><cite>Moon J-S, Nakahira K, Chung K-P, et al. 
RETRACTED ARTICLE: NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat Med. 2016;22(9):1002–1012. doi: 10.1038/nm.4153.
</cite> [<a href="https://doi.org/10.1038/nm.4153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5204248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27455510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=RETRACTED%20ARTICLE:%20NOX4-dependent%20fatty%20acid%20oxidation%20promotes%20NLRP3%20inflammasome%20activation%20in%20macrophages&amp;volume=22&amp;issue=9&amp;publication_year=2016&amp;pages=1002-1012&amp;pmid=27455510&amp;doi=10.1038/nm.4153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC10763623/" class="text-red">Retracted</a>]</li>
<li id="CIT0078">
<span class="label">78.</span><cite>Sokolovska A, Becker CE, Ip WKE, et al. 
Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function. Nat Immunol. 2013;14(6):543–553. doi: 10.1038/ni.2595.
</cite> [<a href="https://doi.org/10.1038/ni.2595" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3708594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23644505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Immunol&amp;title=Activation%20of%20caspase-1%20by%20the%20NLRP3%20inflammasome%20regulates%20the%20NADPH%20oxidase%20NOX2%20to%20control%20phagosome%20function&amp;volume=14&amp;issue=6&amp;publication_year=2013&amp;pages=543-553&amp;pmid=23644505&amp;doi=10.1038/ni.2595&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0079">
<span class="label">79.</span><cite>Vermot A, Petit-Härtlein I, Smith SME, et al. 
NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants (Basel). 2021;10(6):890. doi: 10.3390/antiox10060890.</cite> [<a href="https://doi.org/10.3390/antiox10060890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8228183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34205998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants%20(Basel)&amp;title=NADPH%20oxidases%20(NOX):%20an%20overview%20from%20discovery,%20molecular%20mechanisms%20to%20physiology%20and%20pathology&amp;publication_year=2021&amp;pmid=34205998&amp;doi=10.3390/antiox10060890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0080">
<span class="label">80.</span><cite>Wu M, Han W, Song S, et al. 
NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Mol Cell Endocrinol. 2018;478:115–125. doi: 10.1016/j.mce.2018.08.002.
</cite> [<a href="https://doi.org/10.1016/j.mce.2018.08.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30098377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Endocrinol&amp;title=NLRP3%20deficiency%20ameliorates%20renal%20inflammation%20and%20fibrosis%20in%20diabetic%20mice&amp;volume=478&amp;publication_year=2018&amp;pages=115-125&amp;pmid=30098377&amp;doi=10.1016/j.mce.2018.08.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0081">
<span class="label">81.</span><cite>Duoduo Z, Pengmin J, Ran S, et al. 
Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice. Biomed Pharmacother. 2022;150:112936. doi: 10.1016/j.biopha.2022.112936.</cite> [<a href="https://doi.org/10.1016/j.biopha.2022.112936" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35421784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Pharmacother&amp;title=Ginsenoside%20Rg1%20attenuates%20LPS-induced%20chronic%20renal%20injury%20by%20inhibiting%20NOX4-NLRP3%20signaling%20in%20mice&amp;pmid=35421784&amp;doi=10.1016/j.biopha.2022.112936&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0082">
<span class="label">82.</span><cite>Riley JS, Tait SW.. 
Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020;21(4):e49799. doi: 10.15252/embr.201949799.
</cite> [<a href="https://doi.org/10.15252/embr.201949799" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7132203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32202065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Rep&amp;title=Mitochondrial%20DNA%20in%20inflammation%20and%20immunity&amp;volume=21&amp;issue=4&amp;publication_year=2020&amp;pages=e49799&amp;pmid=32202065&amp;doi=10.15252/embr.201949799&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0083">
<span class="label">83.</span><cite>Zhong Z, Liang S, Sanchez-Lopez E, et al. 
New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018;560(7717):198–203. doi: 10.1038/s41586-018-0372-z.
</cite> [<a href="https://doi.org/10.1038/s41586-018-0372-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6329306/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30046112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=New%20mitochondrial%20DNA%20synthesis%20enables%20NLRP3%20inflammasome%20activation&amp;volume=560&amp;issue=7717&amp;publication_year=2018&amp;pages=198-203&amp;pmid=30046112&amp;doi=10.1038/s41586-018-0372-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0084">
<span class="label">84.</span><cite>Meyer-Schwesinger C.
Lysosome function in glomerular health and disease. Cell Tissue Res. 2021;385(2):371–392. doi: 10.1007/s00441-020-03375-7.
</cite> [<a href="https://doi.org/10.1007/s00441-020-03375-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8523507/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33433692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Tissue%20Res&amp;title=Lysosome%20function%20in%20glomerular%20health%20and%20disease&amp;volume=385&amp;issue=2&amp;publication_year=2021&amp;pages=371-392&amp;pmid=33433692&amp;doi=10.1007/s00441-020-03375-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0085">
<span class="label">85.</span><cite>Xu H, Ren D.. 
Lysosomal Physiology. Annu Rev Physiol. 2015;77(1):57–80. doi: 10.1146/annurev-physiol-021014-071649.
</cite> [<a href="https://doi.org/10.1146/annurev-physiol-021014-071649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4524569/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25668017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Physiol&amp;title=Lysosomal%20Physiology&amp;volume=77&amp;issue=1&amp;publication_year=2015&amp;pages=57-80&amp;pmid=25668017&amp;doi=10.1146/annurev-physiol-021014-071649&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0086">
<span class="label">86.</span><cite>Chevriaux A, Pilot T, Derangère V, et al. 
Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction. Front Cell Dev Biol. 2020;8:167. doi: 10.3389/fcell.2020.00167.
</cite> [<a href="https://doi.org/10.3389/fcell.2020.00167" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7162607/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32328491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Dev%20Biol&amp;title=Cathepsin%20B%20is%20required%20for%20NLRP3%20inflammasome%20activation%20in%20macrophages,%20through%20NLRP3%20interaction&amp;volume=8&amp;publication_year=2020&amp;pages=167&amp;pmid=32328491&amp;doi=10.3389/fcell.2020.00167&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0087">
<span class="label">87.</span><cite>Cocchiaro P, De Pasquale V, Della Morte R, et al. 
The Multifaceted role of the lysosomal protease cathepsins in kidney disease. Front Cell Dev Biol. 2017;5:114. doi: 10.3389/fcell.2017.00114.
</cite> [<a href="https://doi.org/10.3389/fcell.2017.00114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5742100/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29312937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Dev%20Biol&amp;title=The%20Multifaceted%20role%20of%20the%20lysosomal%20protease%20cathepsins%20in%20kidney%20disease&amp;volume=5&amp;publication_year=2017&amp;pages=114&amp;pmid=29312937&amp;doi=10.3389/fcell.2017.00114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0088">
<span class="label">88.</span><cite>Man SM, Kanneganti TD.. 
Regulation of lysosomal dynamics and autophagy by CTSB/cathepsin B. Autophagy. 2016;12(12):2504–2505. doi: 10.1080/15548627.2016.1239679.
</cite> [<a href="https://doi.org/10.1080/15548627.2016.1239679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5173259/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27786577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Autophagy&amp;title=Regulation%20of%20lysosomal%20dynamics%20and%20autophagy%20by%20CTSB/cathepsin%20B&amp;volume=12&amp;issue=12&amp;publication_year=2016&amp;pages=2504-2505&amp;pmid=27786577&amp;doi=10.1080/15548627.2016.1239679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0089">
<span class="label">89.</span><cite>Orlowski GM, Colbert JD, Sharma S, et al. 
Multiple cathepsins promote pro–IL-1β synthesis and NLRP3-Mediated IL-1β activation. J Immunol. 2015;195(4):1685–1697. doi: 10.4049/jimmunol.1500509.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1500509" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4530060/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26195813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol&amp;title=Multiple%20cathepsins%20promote%20pro%E2%80%93IL-1%CE%B2%20synthesis%20and%20NLRP3-Mediated%20IL-1%CE%B2%20activation&amp;volume=195&amp;issue=4&amp;publication_year=2015&amp;pages=1685-1697&amp;pmid=26195813&amp;doi=10.4049/jimmunol.1500509&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0090">
<span class="label">90.</span><cite>Zheng L, Mei W, Zhou J, et al. 
Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation. Exp Ther Med. 2024;27(4):142. doi: 10.3892/etm.2024.12430.
</cite> [<a href="https://doi.org/10.3892/etm.2024.12430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10928820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38476910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Ther%20Med&amp;title=Fluorofenidone%20attenuates%20renal%20fibrosis%20by%20inhibiting%20lysosomal%20cathepsin%E2%80%91mediated%20NLRP3%20inflammasome%20activation&amp;volume=27&amp;issue=4&amp;publication_year=2024&amp;pages=142&amp;pmid=38476910&amp;doi=10.3892/etm.2024.12430&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0091">
<span class="label">91.</span><cite>Bussi C, Heunis T, Pellegrino E, et al. 
Lysosomal damage drives mitochondrial proteome remodelling and reprograms macrophage immunometabolism. Nat Commun. 2022;13(1):7338. doi: 10.1038/s41467-022-34632-8.
</cite> [<a href="https://doi.org/10.1038/s41467-022-34632-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9705561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36443305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Lysosomal%20damage%20drives%20mitochondrial%20proteome%20remodelling%20and%20reprograms%20macrophage%20immunometabolism&amp;volume=13&amp;issue=1&amp;publication_year=2022&amp;pages=7338&amp;pmid=36443305&amp;doi=10.1038/s41467-022-34632-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0092">
<span class="label">92.</span><cite>Hou Y, He H, Ma M, et al. 
Apilimod activates the NLRP3 inflammasome through lysosome-mediated mitochondrial damage. Front Immunol. 2023;14:1128700. doi: 10.3389/fimmu.2023.1128700.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1128700" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10285205/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37359517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Apilimod%20activates%20the%20NLRP3%20inflammasome%20through%20lysosome-mediated%20mitochondrial%20damage&amp;volume=14&amp;publication_year=2023&amp;pages=1128700&amp;pmid=37359517&amp;doi=10.3389/fimmu.2023.1128700&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0093">
<span class="label">93.</span><cite>Wu D, Huang L-F, Chen X-C, et al. 
Research progress on endoplasmic reticulum homeostasis in kidney diseases. Cell Death Dis. 2023;14(7):473. doi: 10.1038/s41419-023-05905-x.
</cite> [<a href="https://doi.org/10.1038/s41419-023-05905-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10374544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37500613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Research%20progress%20on%20endoplasmic%20reticulum%20homeostasis%20in%20kidney%20diseases&amp;volume=14&amp;issue=7&amp;publication_year=2023&amp;pages=473&amp;pmid=37500613&amp;doi=10.1038/s41419-023-05905-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0094">
<span class="label">94.</span><cite>Li W, Cao T, Luo C, et al. 
Crosstalk between ER stress, NLRP3 inflammasome, and inflammation. Appl Microbiol Biotechnol. 2020;104(14):6129–6140. doi: 10.1007/s00253-020-10614-y.
</cite> [<a href="https://doi.org/10.1007/s00253-020-10614-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32447438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Appl%20Microbiol%20Biotechnol&amp;title=Crosstalk%20between%20ER%20stress,%20NLRP3%20inflammasome,%20and%20inflammation&amp;volume=104&amp;issue=14&amp;publication_year=2020&amp;pages=6129-6140&amp;pmid=32447438&amp;doi=10.1007/s00253-020-10614-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0095">
<span class="label">95.</span><cite>Elwakiel A, Mathew A, Isermann B.. 
The role of endoplasmic reticulum-mitochondria-associated membranes in diabetic kidney disease. Cardiovasc Res. 2024;119(18):2875–2883. doi: 10.1093/cvr/cvad190.
</cite> [<a href="https://doi.org/10.1093/cvr/cvad190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38367274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc%20Res&amp;title=The%20role%20of%20endoplasmic%20reticulum-mitochondria-associated%20membranes%20in%20diabetic%20kidney%20disease&amp;volume=119&amp;issue=18&amp;publication_year=2024&amp;pages=2875-2883&amp;pmid=38367274&amp;doi=10.1093/cvr/cvad190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0096">
<span class="label">96.</span><cite>Hu Z-C, Wang B, Zhou X-G, et al. 
Golgi apparatus-targeted photodynamic therapy for enhancing tumor immunogenicity by eliciting NLRP3 protein-dependent pyroptosis. ACS Nano. 2023;17(21):21153–21169. doi: 10.1021/acsnano.3c05005.
</cite> [<a href="https://doi.org/10.1021/acsnano.3c05005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37921421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Golgi%20apparatus-targeted%20photodynamic%20therapy%20for%20enhancing%20tumor%20immunogenicity%20by%20eliciting%20NLRP3%20protein-dependent%20pyroptosis&amp;volume=17&amp;issue=21&amp;publication_year=2023&amp;pages=21153-21169&amp;pmid=37921421&amp;doi=10.1021/acsnano.3c05005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0097">
<span class="label">97.</span><cite>Zhang Z, Meszaros G, He W-T, et al. 
Protein kinase D at the Golgi controls NLRP3 inflammasome activation. J Exp Med. 2017;214(9):2671–2693. doi: 10.1084/jem.20162040.
</cite> [<a href="https://doi.org/10.1084/jem.20162040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5584123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28716882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Exp%20Med&amp;title=Protein%20kinase%20D%20at%20the%20Golgi%20controls%20NLRP3%20inflammasome%20activation&amp;volume=214&amp;issue=9&amp;publication_year=2017&amp;pages=2671-2693&amp;pmid=28716882&amp;doi=10.1084/jem.20162040&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0098">
<span class="label">98.</span><cite>Cuevas S, Pelegrín P.. 
Pyroptosis and redox balance in kidney diseases. Antioxid Redox Signal. 2021;35(1):40–60. doi: 10.1089/ars.2020.8243.
</cite> [<a href="https://doi.org/10.1089/ars.2020.8243" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33559516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxid%20Redox%20Signal&amp;title=Pyroptosis%20and%20redox%20balance%20in%20kidney%20diseases&amp;volume=35&amp;issue=1&amp;publication_year=2021&amp;pages=40-60&amp;pmid=33559516&amp;doi=10.1089/ars.2020.8243&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0099">
<span class="label">99.</span><cite>Jinwen L, Ao C, Kai C, et al. 
New Insights into the mechanisms of pyroptosis and implications for diabetic kidney disease. Int J Mol Sci. 2020;21(19):7057.
</cite> [<a href="https://doi.org/10.3390/ijms21197057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7583981/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32992874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=New%20Insights%20into%20the%20mechanisms%20of%20pyroptosis%20and%20implications%20for%20diabetic%20kidney%20disease&amp;volume=21&amp;issue=19&amp;publication_year=2020&amp;pages=7057&amp;pmid=32992874&amp;doi=10.3390/ijms21197057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0100">
<span class="label">100.</span><cite>Kim YG, Kim S-M, Kim K-P, et al. 
The role of inflammasome-dependent and inflammasome-independent NLRP3 in the kidney. Cells. 2019;8(11):1389. doi: 10.3390/cells8111389.
</cite> [<a href="https://doi.org/10.3390/cells8111389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6912448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31694192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=The%20role%20of%20inflammasome-dependent%20and%20inflammasome-independent%20NLRP3%20in%20the%20kidney&amp;volume=8&amp;issue=11&amp;publication_year=2019&amp;pages=1389&amp;pmid=31694192&amp;doi=10.3390/cells8111389&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0101">
<span class="label">101.</span><cite>Liao L, Tao P, Xu Q, et al. 
Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation. Ren Fail. 2024;46(1):2354444. doi: 10.1080/0886022X.2024.2354444.
</cite> [<a href="https://doi.org/10.1080/0886022X.2024.2354444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11132749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38785272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ren%20Fail&amp;title=Bushen%20Huoxue%20formula%20protects%20against%20renal%20fibrosis%20and%20pyroptosis%20in%20chronic%20kidney%20disease%20by%20inhibiting%20ROS/NLRP3-mediated%20inflammasome%20activation&amp;volume=46&amp;issue=1&amp;publication_year=2024&amp;pages=2354444&amp;pmid=38785272&amp;doi=10.1080/0886022X.2024.2354444&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0102">
<span class="label">102.</span><cite>Yaqiu W, Thirumala-Devi K.. 
From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021;19:4641–4657.
</cite> [<a href="https://doi.org/10.1016/j.csbj.2021.07.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8405902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34504660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Comput%20Struct%20Biotechnol%20J&amp;title=From%20pyroptosis,%20apoptosis%20and%20necroptosis%20to%20PANoptosis:%20a%20mechanistic%20compendium%20of%20programmed%20cell%20death%20pathways&amp;volume=19&amp;publication_year=2021&amp;pages=4641-4657&amp;pmid=34504660&amp;doi=10.1016/j.csbj.2021.07.038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0103">
<span class="label">103.</span><cite>Kaczmarek A, Vandenabeele P, Krysko DV.. 
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity. 2013;38(2):209–223. doi: 10.1016/j.immuni.2013.02.003.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2013.02.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23438821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Necroptosis:%20the%20release%20of%20damage-associated%20molecular%20patterns%20and%20its%20physiological%20relevance&amp;volume=38&amp;issue=2&amp;publication_year=2013&amp;pages=209-223&amp;pmid=23438821&amp;doi=10.1016/j.immuni.2013.02.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0104">
<span class="label">104.</span><cite>Dixon SJ, Lemberg KM, Lamprecht MR, et al. 
Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042.
</cite> [<a href="https://doi.org/10.1016/j.cell.2012.03.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3367386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22632970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Ferroptosis:%20an%20iron-dependent%20form%20of%20nonapoptotic%20cell%20death&amp;volume=149&amp;issue=5&amp;publication_year=2012&amp;pages=1060-1072&amp;pmid=22632970&amp;doi=10.1016/j.cell.2012.03.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0105">
<span class="label">105.</span><cite>Zhou L, Xue X, Hou Q, et al. 
Targeting ferroptosis attenuates interstitial inflammation and kidney fibrosis. Kidney Dis (Basel). 2022;8(1):57–71. doi: 10.1159/000517723.
</cite> [<a href="https://doi.org/10.1159/000517723" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8820137/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35224007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Dis%20(Basel)&amp;title=Targeting%20ferroptosis%20attenuates%20interstitial%20inflammation%20and%20kidney%20fibrosis&amp;volume=8&amp;issue=1&amp;publication_year=2022&amp;pages=57-71&amp;pmid=35224007&amp;doi=10.1159/000517723&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0106">
<span class="label">106.</span><cite>Zhang B, Chen X, Ru F, et al. 
Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis. 2021;12(9):843. doi: 10.1038/s41419-021-04137-1.
</cite> [<a href="https://doi.org/10.1038/s41419-021-04137-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8435531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34511597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Liproxstatin-1%20attenuates%20unilateral%20ureteral%20obstruction-induced%20renal%20fibrosis%20by%20inhibiting%20renal%20tubular%20epithelial%20cells%20ferroptosis&amp;volume=12&amp;issue=9&amp;publication_year=2021&amp;pages=843&amp;pmid=34511597&amp;doi=10.1038/s41419-021-04137-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0107">
<span class="label">107.</span><cite>Zhao Z, Wu J, Xu H, et al. 
XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia-reperfusion injury. Cell Death Dis. 2020;11(8):629. doi: 10.1038/s41419-020-02871-6.
</cite> [<a href="https://doi.org/10.1038/s41419-020-02871-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7429848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32796819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=XJB-5-131%20inhibited%20ferroptosis%20in%20tubular%20epithelial%20cells%20after%20ischemia-reperfusion%20injury&amp;volume=11&amp;issue=8&amp;publication_year=2020&amp;pages=629&amp;pmid=32796819&amp;doi=10.1038/s41419-020-02871-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0108">
<span class="label">108.</span><cite>Chen X, Kang R, Kroemer G, et al. 
Ferroptosis in infection, inflammation, and immunity. J Exp Med. 2021;218(6):e20210518. doi: 10.1084/jem.20210518.</cite> [<a href="https://doi.org/10.1084/jem.20210518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8126980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33978684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Exp%20Med&amp;title=Ferroptosis%20in%20infection,%20inflammation,%20and%20immunity&amp;volume=2021&amp;pmid=33978684&amp;doi=10.1084/jem.20210518&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0109">
<span class="label">109.</span><cite>Wen Y, Zhao C, Chen J, et al. 
Gandouling regulates ferroptosis and improves neuroinflammation in Wilson’s disease through the LCN2/NLRP3 signaling pathway. J Inflamm Res. 2024;17:5599–5618. doi: 10.2147/JIR.S465341.
</cite> [<a href="https://doi.org/10.2147/JIR.S465341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11348929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39193124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Inflamm%20Res&amp;title=Gandouling%20regulates%20ferroptosis%20and%20improves%20neuroinflammation%20in%20Wilson%E2%80%99s%20disease%20through%20the%20LCN2/NLRP3%20signaling%20pathway&amp;volume=17&amp;publication_year=2024&amp;pages=5599-5618&amp;pmid=39193124&amp;doi=10.2147/JIR.S465341&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0110">
<span class="label">110.</span><cite>Kim JW, Nam SA, Koh E-S, et al. 
The Impairment of Endothelial Autophagy Accelerates Renal Senescence by Ferroptosis and NLRP3 Inflammasome Signaling Pathways with the Disruption of Endothelial Barrier. <em>Antioxidants (Basel)</em>. 2024;13(8):886. doi: 10.3390/antiox13080886.</cite> [<a href="https://doi.org/10.3390/antiox13080886" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11351978/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39199133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20JW,%20Nam%20SA,%20Koh%20E-S,%20et%20al.%20The%20Impairment%20of%20Endothelial%20Autophagy%20Accelerates%20Renal%20Senescence%20by%20Ferroptosis%20and%20NLRP3%20Inflammasome%20Signaling%20Pathways%20with%20the%20Disruption%20of%20Endothelial%20Barrier.%20Antioxidants%20(Basel).%202024;13(8):886.%20doi:%2010.3390/antiox13080886." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0111">
<span class="label">111.</span><cite>Forcina GC, Dixon SJ.. 
GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19(18):e1800311. doi: 10.1002/pmic.201800311.
</cite> [<a href="https://doi.org/10.1002/pmic.201800311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30888116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=GPX4%20at%20the%20crossroads%20of%20lipid%20homeostasis%20and%20ferroptosis&amp;volume=19&amp;issue=18&amp;publication_year=2019&amp;pages=e1800311&amp;pmid=30888116&amp;doi=10.1002/pmic.201800311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0112">
<span class="label">112.</span><cite>Zhou Y, Zhou H, Hua L, et al. 
Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis. Free Radic Biol Med. 2021;171:55–68. doi: 10.1016/j.freeradbiomed.2021.05.009.
</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2021.05.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33974977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radic%20Biol%20Med&amp;title=Verification%20of%20ferroptosis%20and%20pyroptosis%20and%20identification%20of%20PTGS2%20as%20the%20hub%20gene%20in%20human%20coronary%20artery%20atherosclerosis&amp;volume=171&amp;publication_year=2021&amp;pages=55-68&amp;pmid=33974977&amp;doi=10.1016/j.freeradbiomed.2021.05.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0113">
<span class="label">113.</span><cite>Meijers BK, Evenepoel P.. 
The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant. 2011;26(3):759–761. doi: 10.1093/ndt/gfq818.
</cite> [<a href="https://doi.org/10.1093/ndt/gfq818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21343587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=The%20gut-kidney%20axis:%20indoxyl%20sulfate,%20p-cresyl%20sulfate%20and%20CKD%20progression&amp;volume=26&amp;issue=3&amp;publication_year=2011&amp;pages=759-761&amp;pmid=21343587&amp;doi=10.1093/ndt/gfq818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0114">
<span class="label">114.</span><cite>Pan H, Jian Y, Wang F, et al. 
NLRP3 and gut microbiota homeostasis: progress in research. Cells. 2022;11(23):3758. doi: 10.3390/cells11233758.
</cite> [<a href="https://doi.org/10.3390/cells11233758" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9739202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36497018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=NLRP3%20and%20gut%20microbiota%20homeostasis:%20progress%20in%20research&amp;volume=11&amp;issue=23&amp;publication_year=2022&amp;pages=3758&amp;pmid=36497018&amp;doi=10.3390/cells11233758&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0115">
<span class="label">115.</span><cite>Long C, Zhang C, Xie Y.. 
Study on the mechanism of hirudin multi target delaying renal function decline in chronic kidney disease based on the "gut-kidney axis" theory. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(10):7951–7962. doi: 10.1007/s00210-023-02888-6.
</cite> [<a href="https://doi.org/10.1007/s00210-023-02888-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11450085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38758227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Naunyn%20Schmiedebergs%20Arch%20Pharmacol&amp;title=Study%20on%20the%20mechanism%20of%20hirudin%20multi%20target%20delaying%20renal%20function%20decline%20in%20chronic%20kidney%20disease%20based%20on%20the%20%22gut-kidney%20axis%22%20theory&amp;volume=397&amp;issue=10&amp;publication_year=2024&amp;pages=7951-7962&amp;pmid=38758227&amp;doi=10.1007/s00210-023-02888-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0116">
<span class="label">116.</span><cite>Pan S, Jiang S-S, Li R, et al. 
Hong Guo Ginseng Guo (HGGG) protects against kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome and regulating intestinal flora. Phytomedicine. 2024;132:155861. doi: 10.1016/j.phymed.2024.155861.
</cite> [<a href="https://doi.org/10.1016/j.phymed.2024.155861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39024672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytomedicine&amp;title=Hong%20Guo%20Ginseng%20Guo%20(HGGG)%20protects%20against%20kidney%20injury%20in%20diabetic%20nephropathy%20by%20inhibiting%20NLRP3%20inflammasome%20and%20regulating%20intestinal%20flora&amp;volume=132&amp;publication_year=2024&amp;pages=155861&amp;pmid=39024672&amp;doi=10.1016/j.phymed.2024.155861&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0117">
<span class="label">117.</span><cite>Tian X, Zeng Y, Tu Q, et al. 
Butyrate alleviates renal fibrosis in CKD by regulating NLRP3-mediated pyroptosis via the STING/NF-κB/p65 pathway. Int Immunopharmacol. 2023;124(Pt B):111010. doi: 10.1016/j.intimp.2023.111010.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2023.111010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37852118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Immunopharmacol&amp;title=Butyrate%20alleviates%20renal%20fibrosis%20in%20CKD%20by%20regulating%20NLRP3-mediated%20pyroptosis%20via%20the%20STING/NF-%CE%BAB/p65%20pathway&amp;volume=124&amp;issue=Pt%20B&amp;publication_year=2023&amp;pages=111010&amp;pmid=37852118&amp;doi=10.1016/j.intimp.2023.111010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0118">
<span class="label">118.</span><cite>Ramos CI, Armani RG, Canziani MEF, et al. 
Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial. Nephrol Dial Transplant. 2019;34(11):1876–1884. doi: 10.1093/ndt/gfy171.
</cite> [<a href="https://doi.org/10.1093/ndt/gfy171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29939302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Effect%20of%20prebiotic%20(fructooligosaccharide)%20on%20uremic%20toxins%20of%20chronic%20kidney%20disease%20patients:%20a%20randomized%20controlled%20trial&amp;volume=34&amp;issue=11&amp;publication_year=2019&amp;pages=1876-1884&amp;pmid=29939302&amp;doi=10.1093/ndt/gfy171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0119">
<span class="label">119.</span><cite>Wang J, Jiang M, Li X, et al. 
Inulin supplementation alleviates ochratoxin a-induced kidney injury through modulating intestinal microbiota. J Agric Food Chem. 2024;72(33):18682–18696. doi: 10.1021/acs.jafc.4c04382.
</cite> [<a href="https://doi.org/10.1021/acs.jafc.4c04382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39135376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Agric%20Food%20Chem&amp;title=Inulin%20supplementation%20alleviates%20ochratoxin%20a-induced%20kidney%20injury%20through%20modulating%20intestinal%20microbiota&amp;volume=72&amp;issue=33&amp;publication_year=2024&amp;pages=18682-18696&amp;pmid=39135376&amp;doi=10.1021/acs.jafc.4c04382&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0120">
<span class="label">120.</span><cite>Lichtnekert J, Anders H-J.. 
Lupus nephritis-related chronic kidney disease. Nat Rev Rheumatol. 2024;20(11):699–711. doi: 10.1038/s41584-024-01158-w.
</cite> [<a href="https://doi.org/10.1038/s41584-024-01158-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39317803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Rheumatol&amp;title=Lupus%20nephritis-related%20chronic%20kidney%20disease&amp;volume=20&amp;issue=11&amp;publication_year=2024&amp;pages=699-711&amp;pmid=39317803&amp;doi=10.1038/s41584-024-01158-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0121">
<span class="label">121.</span><cite>Lin T-A, Wu VC-C, Wang C-Y.. 
Autophagy in chronic kidney diseases. Cells. 2019;8(1):61. doi: 10.3390/cells8010061.
</cite> [<a href="https://doi.org/10.3390/cells8010061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6357204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30654583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Autophagy%20in%20chronic%20kidney%20diseases&amp;volume=8&amp;issue=1&amp;publication_year=2019&amp;pages=61&amp;pmid=30654583&amp;doi=10.3390/cells8010061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0122">
<span class="label">122.</span><cite>Wang Y-J, Chen Y-Y, Hsiao C-M, et al. 
Induction of autophagy by pterostilbene contributes to the prevention of renal fibrosis via attenuating NLRP3 inflammasome activation and epithelial-mesenchymal transition. Front Cell Dev Biol. 2020;8:436. volume2020. doi: 10.3389/fcell.2020.00436.
</cite> [<a href="https://doi.org/10.3389/fcell.2020.00436" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7283393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32582712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Dev%20Biol&amp;title=Induction%20of%20autophagy%20by%20pterostilbene%20contributes%20to%20the%20prevention%20of%20renal%20fibrosis%20via%20attenuating%20NLRP3%20inflammasome%20activation%20and%20epithelial-mesenchymal%20transition&amp;volume=8&amp;publication_year=2020&amp;pages=436&amp;pmid=32582712&amp;doi=10.3389/fcell.2020.00436&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0123">
<span class="label">123.</span><cite>Ding H, Li J, Li Y, et al. 
MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome. Mol Ther. 2021;29(7):2308–2320. doi: 10.1016/j.ymthe.2021.03.012.
</cite> [<a href="https://doi.org/10.1016/j.ymthe.2021.03.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8261077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33744467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther&amp;title=MicroRNA-10%20negatively%20regulates%20inflammation%20in%20diabetic%20kidney%20via%20targeting%20activation%20of%20the%20NLRP3%20inflammasome&amp;volume=29&amp;issue=7&amp;publication_year=2021&amp;pages=2308-2320&amp;pmid=33744467&amp;doi=10.1016/j.ymthe.2021.03.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0124">
<span class="label">124.</span><cite>Ming Y, Li Z.. 
The selective NLRP3-inflammasome inhibitor CY-09 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3- inflammasome activation. Curr Med Chem. 2023;30(28):3261–3270.
</cite> [<a href="https://doi.org/10.2174/0929867329666220922104654" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36154582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Med%20Chem&amp;title=The%20selective%20NLRP3-inflammasome%20inhibitor%20CY-09%20ameliorates%20kidney%20injury%20in%20diabetic%20nephropathy%20by%20inhibiting%20NLRP3-%20inflammasome%20activation&amp;volume=30&amp;issue=28&amp;publication_year=2023&amp;pages=3261-3270&amp;pmid=36154582&amp;doi=10.2174/0929867329666220922104654&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0125">
<span class="label">125.</span><cite>Gu C, Liu S, Wang H, et al. 
Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD‑like receptor protein 3 inflammatory corpuscle. Int J Mol Med. 2019;43(6):2440–2450.
</cite> [<a href="https://doi.org/10.3892/ijmm.2019.4163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6488169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31017263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Med&amp;title=Role%20of%20the%20thioredoxin%20interacting%20protein%20in%20diabetic%20nephropathy%20and%20the%20mechanism%20of%20regulating%20NOD%E2%80%91like%20receptor%20protein%203%20inflammatory%20corpuscle&amp;volume=43&amp;issue=6&amp;publication_year=2019&amp;pages=2440-2450&amp;pmid=31017263&amp;doi=10.3892/ijmm.2019.4163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0126">
<span class="label">126.</span><cite>Wu M, Yang Z, Zhang C, et al. 
Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metabolism. 2021;118:154748. doi: 10.1016/j.metabol.2021.154748.
</cite> [<a href="https://doi.org/10.1016/j.metabol.2021.154748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33675822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=Inhibition%20of%20NLRP3%20inflammasome%20ameliorates%20podocyte%20damage%20by%20suppressing%20lipid%20accumulation%20in%20diabetic%20nephropathy&amp;volume=118&amp;publication_year=2021&amp;pages=154748&amp;pmid=33675822&amp;doi=10.1016/j.metabol.2021.154748&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0127">
<span class="label">127.</span><cite>Lei F.
Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy. FASEB J. 2018;33(3):4571–4585.
</cite> [<a href="https://doi.org/10.1096/fj.201801749RRR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30571313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J&amp;title=Optineurin%20inhibits%20NLRP3%20inflammasome%20activation%20by%20enhancing%20mitophagy%20of%20renal%20tubular%20cells%20in%20diabetic%20nephropathy&amp;volume=33&amp;issue=3&amp;publication_year=2018&amp;pages=4571-4585&amp;pmid=30571313&amp;doi=10.1096/fj.201801749RRR&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0128">
<span class="label">128.</span><cite>Shen J, Dai Z, Li Y, et al. 
TLR9 regulates NLRP3 inflammasome activation via the NF-κB signaling pathway in diabetic nephropathy. Diabetol Metab Syndr. 2022;14(1):26. doi: 10.1186/s13098-021-00780-y.
</cite> [<a href="https://doi.org/10.1186/s13098-021-00780-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8815223/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35120573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetol%20Metab%20Syndr&amp;title=TLR9%20regulates%20NLRP3%20inflammasome%20activation%20via%20the%20NF-%CE%BAB%20signaling%20pathway%20in%20diabetic%20nephropathy&amp;volume=14&amp;issue=1&amp;publication_year=2022&amp;pages=26&amp;pmid=35120573&amp;doi=10.1186/s13098-021-00780-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0129">
<span class="label">129.</span><cite>Zhang K, Fan C, Cai D, et al. 
Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease. Front Cell Dev Biol. 2020;8:1. doi: 10.3389/fcell.2020.00001.
</cite> [<a href="https://doi.org/10.3389/fcell.2020.00001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7012792/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32117956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Dev%20Biol&amp;title=Contribution%20of%20TGF-Beta-Mediated%20NLRP3-HMGB1%20Activation%20to%20Tubulointerstitial%20Fibrosis%20in%20Rat%20With%20Angiotensin%20II-Induced%20Chronic%20Kidney%20Disease&amp;volume=8&amp;publication_year=2020&amp;pages=1&amp;pmid=32117956&amp;doi=10.3389/fcell.2020.00001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0130">
<span class="label">130.</span><cite>Krishnan SM, Ling YH, Huuskes BM, et al. 
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res. 2019;115(4):776–787. doi: 10.1093/cvr/cvy252.
</cite> [<a href="https://doi.org/10.1093/cvr/cvy252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6432065/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30357309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc%20Res&amp;title=Pharmacological%20inhibition%20of%20the%20NLRP3%20inflammasome%20reduces%20blood%20pressure,%20renal%20damage,%20and%20dysfunction%20in%20salt-sensitive%20hypertension&amp;volume=115&amp;issue=4&amp;publication_year=2019&amp;pages=776-787&amp;pmid=30357309&amp;doi=10.1093/cvr/cvy252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0131">
<span class="label">131.</span><cite>Bai X, Wang Y, Liu P, et al. 
Sodium butyrate regulation of NLRP3-Ser295 phosphorylation inhibits hypertensive nephropathy. J Funct Foods. 2023;107:105670. doi: 10.1016/j.jff.2023.105670.</cite> [<a href="https://doi.org/10.1016/j.jff.2023.105670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Funct%20Foods&amp;title=Sodium%20butyrate%20regulation%20of%20NLRP3-Ser295%20phosphorylation%20inhibits%20hypertensive%20nephropathy&amp;volume=107&amp;publication_year=2023&amp;pages=105670&amp;doi=10.1016/j.jff.2023.105670&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0132">
<span class="label">132.</span><cite>Tsai Y-L, Hua K-F, Chen A, et al. 
NLRP3 inflammasome: pathogenic role and potential therapeutic target for IgA nephropathy. Sci Rep. 2017;7(1):41123. doi: 10.1038/srep41123.
</cite> [<a href="https://doi.org/10.1038/srep41123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5259731/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28117341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=NLRP3%20inflammasome:%20pathogenic%20role%20and%20potential%20therapeutic%20target%20for%20IgA%20nephropathy&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=41123&amp;pmid=28117341&amp;doi=10.1038/srep41123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0133">
<span class="label">133.</span><cite>Hua K-F, Yang S-M, Kao T-Y, et al. 
Osthole mitigates progressive iga nephropathy by inhibiting ROS generation and NF-κB/NLRP3 pathway. PLoS One. 2013;8(10):e77794. doi: 10.1371/journal.pone.0077794.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0077794" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3810132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24204969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Osthole%20mitigates%20progressive%20iga%20nephropathy%20by%20inhibiting%20ROS%20generation%20and%20NF-%CE%BAB/NLRP3%20pathway&amp;volume=8&amp;issue=10&amp;publication_year=2013&amp;pages=e77794&amp;pmid=24204969&amp;doi=10.1371/journal.pone.0077794&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0134">
<span class="label">134.</span><cite>Chun J, Chung H, Wang X, et al. 
NLRP3 localizes to the tubular epithelium in human kidney and correlates with outcome in IgA nephropathy. Sci Rep. 2016;6(1):24667. doi: 10.1038/srep24667.
</cite> [<a href="https://doi.org/10.1038/srep24667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4837396/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27093923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=NLRP3%20localizes%20to%20the%20tubular%20epithelium%20in%20human%20kidney%20and%20correlates%20with%20outcome%20in%20IgA%20nephropathy&amp;volume=6&amp;issue=1&amp;publication_year=2016&amp;pages=24667&amp;pmid=27093923&amp;doi=10.1038/srep24667&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0135">
<span class="label">135.</span><cite>Peng W, Pei G-Q, Tang Y, et al. 
IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy. J Transl Med. 2019;17(1):406. doi: 10.1186/s12967-019-02157-2.
</cite> [<a href="https://doi.org/10.1186/s12967-019-02157-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6891954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31796125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Transl%20Med&amp;title=IgA1%20deposition%20may%20induce%20NLRP3%20expression%20and%20macrophage%20transdifferentiation%20of%20podocyte%20in%20IgA%20nephropathy&amp;volume=17&amp;issue=1&amp;publication_year=2019&amp;pages=406&amp;pmid=31796125&amp;doi=10.1186/s12967-019-02157-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0136">
<span class="label">136.</span><cite>Wu C-Y, Hua K-F, Yang S-R, et al. 
Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1- and SIRT3-mediated autophagy induction. J Cell Mol Med. 2020;24(23):13609–13622. doi: 10.1111/jcmm.15663.
</cite> [<a href="https://doi.org/10.1111/jcmm.15663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7753881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33135320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Mol%20Med&amp;title=Tris%20DBA%20ameliorates%20IgA%20nephropathy%20by%20blunting%20the%20activating%20signal%20of%20NLRP3%20inflammasome%20through%20SIRT1-%20and%20SIRT3-mediated%20autophagy%20induction&amp;volume=24&amp;issue=23&amp;publication_year=2020&amp;pages=13609-13622&amp;pmid=33135320&amp;doi=10.1111/jcmm.15663&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0137">
<span class="label">137.</span><cite>Tan J, Dong L, Jiang Z, et al. 
Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling. J Transl Med. 2022;20(1):382. doi: 10.1186/s12967-022-03585-3.
</cite> [<a href="https://doi.org/10.1186/s12967-022-03585-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9422169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36038927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Transl%20Med&amp;title=Probiotics%20ameliorate%20IgA%20nephropathy%20by%20improving%20gut%20dysbiosis%20and%20blunting%20NLRP3%20signaling&amp;volume=20&amp;issue=1&amp;publication_year=2022&amp;pages=382&amp;pmid=36038927&amp;doi=10.1186/s12967-022-03585-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0138">
<span class="label">138.</span><cite>Zheng L, Zhu Y, Ma Y, et al. 
Relationship between hyperuricemia and the risk of cardiovascular events and chronic kidney disease in both the general population and hypertensive patients: a systematic review and meta-analysis. Int J Cardiol. 2024;399:131779. doi: 10.1016/j.ijcard.2024.131779.
</cite> [<a href="https://doi.org/10.1016/j.ijcard.2024.131779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38218247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cardiol&amp;title=Relationship%20between%20hyperuricemia%20and%20the%20risk%20of%20cardiovascular%20events%20and%20chronic%20kidney%20disease%20in%20both%20the%20general%20population%20and%20hypertensive%20patients:%20a%20systematic%20review%20and%20meta-analysis&amp;volume=399&amp;publication_year=2024&amp;pages=131779&amp;pmid=38218247&amp;doi=10.1016/j.ijcard.2024.131779&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0139">
<span class="label">139.</span><cite>Braga TT, Forni MF, Correa-Costa M, et al. 
Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7(1):39884. doi: 10.1038/srep39884.
</cite> [<a href="https://doi.org/10.1038/srep39884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5233987/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28084303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Soluble%20uric%20acid%20activates%20the%20NLRP3%20inflammasome&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=39884&amp;pmid=28084303&amp;doi=10.1038/srep39884&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0140">
<span class="label">140.</span><cite>Hu Y, Shi Y, Chen H, et al. 
Blockade of autophagy prevents the progression of hyperuricemic nephropathy through inhibiting NLRP3 inflammasome-mediated pyroptosis. Front Immunol. 2022;13:858494. doi: 10.3389/fimmu.2022.858494.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.858494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8924517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35309342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Blockade%20of%20autophagy%20prevents%20the%20progression%20of%20hyperuricemic%20nephropathy%20through%20inhibiting%20NLRP3%20inflammasome-mediated%20pyroptosis&amp;volume=13&amp;publication_year=2022&amp;pages=858494&amp;pmid=35309342&amp;doi=10.3389/fimmu.2022.858494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0141">
<span class="label">141.</span><cite>Wu Y, He F, Li Y, et al. 
Effects of shizhifang on NLRP3 inflammasome activation and renal tubular injury in hyperuricemic rats. Evid Based Complement Alternat Med. 2017;2017(1):7674240. doi: 10.1155/2017/7674240.
</cite> [<a href="https://doi.org/10.1155/2017/7674240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5735790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29358971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Evid%20Based%20Complement%20Alternat%20Med&amp;title=Effects%20of%20shizhifang%20on%20NLRP3%20inflammasome%20activation%20and%20renal%20tubular%20injury%20in%20hyperuricemic%20rats&amp;volume=2017&amp;issue=1&amp;publication_year=2017&amp;pages=7674240&amp;pmid=29358971&amp;doi=10.1155/2017/7674240&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0142">
<span class="label">142.</span><cite>Lin X, Zou X, Hu B, et al. 
Bi Xie Fen Qing Yin decoction alleviates potassium oxonate and adenine induced-hyperuricemic nephropathy in mice by modulating gut microbiota and intestinal metabolites. Biomed Pharmacother. 2024;170:116022. doi: 10.1016/j.biopha.2023.116022.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.116022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38147734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Pharmacother&amp;title=Bi%20Xie%20Fen%20Qing%20Yin%20decoction%20alleviates%20potassium%20oxonate%20and%20adenine%20induced-hyperuricemic%20nephropathy%20in%20mice%20by%20modulating%20gut%20microbiota%20and%20intestinal%20metabolites&amp;volume=170&amp;publication_year=2024&amp;pages=116022&amp;pmid=38147734&amp;doi=10.1016/j.biopha.2023.116022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0143">
<span class="label">143.</span><cite>Hsu CY, McCulloch CE, Iribarren C, et al. 
Body mass index and risk for ESRD. Ann Intern Med. 2006;144(1):21–28. doi: 10.7326/0003-4819-144-1-200601030-00006.
</cite> [<a href="https://doi.org/10.7326/0003-4819-144-1-200601030-00006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16389251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Intern%20Med&amp;title=Body%20mass%20index%20and%20risk%20for%20ESRD&amp;volume=144&amp;issue=1&amp;publication_year=2006&amp;pages=21-28&amp;pmid=16389251&amp;doi=10.7326/0003-4819-144-1-200601030-00006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0144">
<span class="label">144.</span><cite>Boini KM, Xia M, Abais JM, et al. 
Activation of inflammasomes in podocyte injury of mice on the high fat diet: effects of ASC gene deletion and silencing. Biochim Biophys Acta. 2014;1843(5):836–845. doi: 10.1016/j.bbamcr.2014.01.033.
</cite> [<a href="https://doi.org/10.1016/j.bbamcr.2014.01.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3986924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24508291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochim%20Biophys%20Acta&amp;title=Activation%20of%20inflammasomes%20in%20podocyte%20injury%20of%20mice%20on%20the%20high%20fat%20diet:%20effects%20of%20ASC%20gene%20deletion%20and%20silencing&amp;volume=1843&amp;issue=5&amp;publication_year=2014&amp;pages=836-845&amp;pmid=24508291&amp;doi=10.1016/j.bbamcr.2014.01.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0145">
<span class="label">145.</span><cite>Hou X-X, Dong H-R, Sun L-J, et al. 
Purinergic 2X7 receptor is involved in the podocyte damage of obesity-related glomerulopathy via activating nucleotide-binding and oligomerization domain-like receptor protein 3 inflammasome. Chin Med J (Engl). 2018;131(22):2713–2725. doi: 10.4103/0366-6999.245270.
</cite> [<a href="https://doi.org/10.4103/0366-6999.245270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6247604/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30425198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chin%20Med%20J%20(Engl)&amp;title=Purinergic%202X7%20receptor%20is%20involved%20in%20the%20podocyte%20damage%20of%20obesity-related%20glomerulopathy%20via%20activating%20nucleotide-binding%20and%20oligomerization%20domain-like%20receptor%20protein%203%20inflammasome&amp;volume=131&amp;issue=22&amp;publication_year=2018&amp;pages=2713-2725&amp;pmid=30425198&amp;doi=10.4103/0366-6999.245270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0146">
<span class="label">146.</span><cite>Xu X, Huang X, Zhang L, et al. 
Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammasome pathway. BMC Nephrol. 2021;22(1):218. doi: 10.1186/s12882-021-02391-1.
</cite> [<a href="https://doi.org/10.1186/s12882-021-02391-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8191043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34107901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Nephrol&amp;title=Adiponectin%20protects%20obesity-related%20glomerulopathy%20by%20inhibiting%20ROS/NF-%CE%BAB/NLRP3%20inflammasome%20pathway&amp;volume=22&amp;issue=1&amp;publication_year=2021&amp;pages=218&amp;pmid=34107901&amp;doi=10.1186/s12882-021-02391-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0147">
<span class="label">147.</span><cite>Martínez-Klimova E, Aparicio-Trejo OE, Tapia E, et al. 
Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments. Biomolecules. 2019;9(4):141. doi: 10.3390/biom9040141.
</cite> [<a href="https://doi.org/10.3390/biom9040141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6523883/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30965656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=Unilateral%20ureteral%20obstruction%20as%20a%20model%20to%20investigate%20fibrosis-attenuating%20treatments&amp;volume=9&amp;issue=4&amp;publication_year=2019&amp;pages=141&amp;pmid=30965656&amp;doi=10.3390/biom9040141&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0148">
<span class="label">148.</span><cite>Tung-Wei H, Yi-Hsien H, Hsiang-Lin L, et al. 
Renoprotective effect of rosmarinic acid by inhibition of indoxyl sulfate-induced renal interstitial fibrosis via the NLRP3 inflammasome signaling. Int Immunopharmacol. 2024;135:112314. doi: 10.1016/j.intimp.2024.112314.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2024.112314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38788450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Immunopharmacol&amp;title=Renoprotective%20effect%20of%20rosmarinic%20acid%20by%20inhibition%20of%20indoxyl%20sulfate-induced%20renal%20interstitial%20fibrosis%20via%20the%20NLRP3%20inflammasome%20signaling&amp;volume=135&amp;publication_year=2024&amp;pages=112314&amp;pmid=38788450&amp;doi=10.1016/j.intimp.2024.112314&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0149">
<span class="label">149.</span><cite>Honglei G, Ping XB, Shijian Z, et al. 
NLRP3 deficiency attenuates renal fibrosis and ameliorates mitochondrial dysfunction in a mouse unilateral ureteral obstruction model of chronic kidney disease. Mediators Inflamm. 2017;2017:8316560. doi: 10.1155/2017/8316560.</cite> [<a href="https://doi.org/10.1155/2017/8316560" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5350413/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28348462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mediators%20Inflamm&amp;title=NLRP3%20deficiency%20attenuates%20renal%20fibrosis%20and%20ameliorates%20mitochondrial%20dysfunction%20in%20a%20mouse%20unilateral%20ureteral%20obstruction%20model%20of%20chronic%20kidney%20disease&amp;volume=2017&amp;publication_year=2017&amp;pmid=28348462&amp;doi=10.1155/2017/8316560&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0150">
<span class="label">150.</span><cite>Vilaysane A, Chun J, Seamone ME, et al. 
The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010;21(10):1732–1744. doi: 10.1681/ASN.2010020143.
</cite> [<a href="https://doi.org/10.1681/ASN.2010020143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3013544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20688930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Soc%20Nephrol&amp;title=The%20NLRP3%20inflammasome%20promotes%20renal%20inflammation%20and%20contributes%20to%20CKD&amp;volume=21&amp;issue=10&amp;publication_year=2010&amp;pages=1732-1744&amp;pmid=20688930&amp;doi=10.1681/ASN.2010020143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0151">
<span class="label">151.</span><cite>Liu N, Gao Y, Liu Y, et al. 
GBP5 inhibition ameliorates the progression of lupus nephritis by suppressing NLRP3 inflammasome activation. Immunol Invest. 2023;52(1):52–66. doi: 10.1080/08820139.2022.2122834.
</cite> [<a href="https://doi.org/10.1080/08820139.2022.2122834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36175170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunol%20Invest&amp;title=GBP5%20inhibition%20ameliorates%20the%20progression%20of%20lupus%20nephritis%20by%20suppressing%20NLRP3%20inflammasome%20activation&amp;volume=52&amp;issue=1&amp;publication_year=2023&amp;pages=52-66&amp;pmid=36175170&amp;doi=10.1080/08820139.2022.2122834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0152">
<span class="label">152.</span><cite>Yang S-R, Hsu W-H, Wu C-Y, et al. 
A. Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis. Faseb J. 2020;34(10):13284–13299. doi: 10.1096/fj.202001326R.
</cite> [<a href="https://doi.org/10.1096/fj.202001326R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32813287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Faseb%20J&amp;title=A.%20Accelerated,%20severe%20lupus%20nephritis%20benefits%20from%20treatment%20with%20honokiol%20by%20immunoregulation%20and%20differentially%20regulating%20NF-%CE%BAB/NLRP3%20inflammasome%20and%20sirtuin%201/autophagy%20axis&amp;volume=34&amp;issue=10&amp;publication_year=2020&amp;pages=13284-13299&amp;pmid=32813287&amp;doi=10.1096/fj.202001326R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0153">
<span class="label">153.</span><cite>Simona G.
NLRP3 inflammasome activation in dialyzed chronic kidney disease patients. PLoS One. 2015;10(3):e0122272–e0122272.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0122272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4370586/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25798846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=NLRP3%20inflammasome%20activation%20in%20dialyzed%20chronic%20kidney%20disease%20patients&amp;volume=10&amp;issue=3&amp;publication_year=2015&amp;pages=e0122272-e0122272&amp;pmid=25798846&amp;doi=10.1371/journal.pone.0122272&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0154">
<span class="label">154.</span><cite>Chen Z, Liu L, Gao C, et al. 
Astragali radix (Huangqi): a promising edible immunomodulatory herbal medicine. J Ethnopharmacol. 2020;258:112895. doi: 10.1016/j.jep.2020.112895.
</cite> [<a href="https://doi.org/10.1016/j.jep.2020.112895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32330511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Ethnopharmacol&amp;title=Astragali%20radix%20(Huangqi):%20a%20promising%20edible%20immunomodulatory%20herbal%20medicine&amp;volume=258&amp;publication_year=2020&amp;pages=112895&amp;pmid=32330511&amp;doi=10.1016/j.jep.2020.112895&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0155">
<span class="label">155.</span><cite>Sun H, Wang W, Han P, et al. 
Astragaloside IV ameliorates renal injury in <em>db/db</em> mice. Sci Rep. 2016;6(1):32545. doi: 10.1038/srep32545.
</cite> [<a href="https://doi.org/10.1038/srep32545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5009300/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27585918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Astragaloside%20IV%20ameliorates%20renal%20injury%20in%20db/db%20mice&amp;volume=6&amp;issue=1&amp;publication_year=2016&amp;pages=32545&amp;pmid=27585918&amp;doi=10.1038/srep32545&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0156">
<span class="label">156.</span><cite>Yuan Y, Yufan W, Minhui H, et al. 
Astragaloside IV protects against podocyte injury by upregulating mitophagy via the Mfn2/Pink1/parkin axis. Curr Mol Med. 2024;25(7):871–881. doi: 10.2174/0115665240310818240531080353.</cite> [<a href="https://doi.org/10.2174/0115665240310818240531080353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38867537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Mol%20Med&amp;title=Astragaloside%20IV%20protects%20against%20podocyte%20injury%20by%20upregulating%20mitophagy%20via%20the%20Mfn2/Pink1/parkin%20axis&amp;publication_year=2024&amp;pmid=38867537&amp;doi=10.2174/0115665240310818240531080353&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0157">
<span class="label">157.</span><cite>Chen Q, Su Y, Ju Y, et al. 
Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis. Biomed Pharmacother. 2018;108:679–686. doi: 10.1016/j.biopha.2018.09.049.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2018.09.049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30245468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Pharmacother&amp;title=Astragalosides%20IV%20protected%20the%20renal%20tubular%20epithelial%20cells%20from%20free%20fatty%20acids-induced%20injury%20by%20reducing%20oxidative%20stress%20and%20apoptosis&amp;volume=108&amp;publication_year=2018&amp;pages=679-686&amp;pmid=30245468&amp;doi=10.1016/j.biopha.2018.09.049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0158">
<span class="label">158.</span><cite>Li X, Dong X, Zhang L, et al. 
Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation. Front Pharmacol. 2024;15:1285797. doi: 10.3389/fphar.2024.1285797.
</cite> [<a href="https://doi.org/10.3389/fphar.2024.1285797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10987761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Astragaloside%20IV%20attenuates%20renal%20tubule%20injury%20in%20DKD%20rats%20via%20suppression%20of%20CD36-mediated%20NLRP3%20inflammasome%20activation&amp;volume=15&amp;publication_year=2024&amp;pages=1285797&amp;pmid=38572426&amp;doi=10.3389/fphar.2024.1285797&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0159">
<span class="label">159.</span><cite>Xie J, Ma X, Zheng Y, et al. 
<em>Panax notoginseng saponins</em> alleviate damage to the intestinal barrier and regulate levels of intestinal microbes in a rat model of chronic kidney disease. Ren Fail. 2022;44(1):1948–1960. doi: 10.1080/0886022X.2022.2143378.
</cite> [<a href="https://doi.org/10.1080/0886022X.2022.2143378" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9662016/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36354128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ren%20Fail&amp;title=Panax%20notoginseng%20saponins%20alleviate%20damage%20to%20the%20intestinal%20barrier%20and%20regulate%20levels%20of%20intestinal%20microbes%20in%20a%20rat%20model%20of%20chronic%20kidney%20disease&amp;volume=44&amp;issue=1&amp;publication_year=2022&amp;pages=1948-1960&amp;pmid=36354128&amp;doi=10.1080/0886022X.2022.2143378&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0160">
<span class="label">160.</span><cite>Jing X, Xin M, Xueying L, et al. 
<em>Panax notoginseng</em> Saponins alleviate LPS-induced Fibrosis of HK-2 cells by inhibiting the activation of NLRP3 inflammasome and pyroptosis. Curr Pharm Biotechnol. 2023;25(1):113–123. doi: 10.2174/1389201024666230417084507.</cite> [<a href="https://doi.org/10.2174/1389201024666230417084507" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37073148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Pharm%20Biotechnol&amp;title=Panax%20notoginseng%20Saponins%20alleviate%20LPS-induced%20Fibrosis%20of%20HK-2%20cells%20by%20inhibiting%20the%20activation%20of%20NLRP3%20inflammasome%20and%20pyroptosis&amp;volume=25&amp;issue=1&amp;publication_year=2023&amp;pages=113-123&amp;pmid=37073148&amp;doi=10.2174/1389201024666230417084507&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0161">
<span class="label">161.</span><cite>Rauf A, Olatunde A, Imran M, et al. 
Honokiol: A review of its pharmacological potential and therapeutic insights. Phytomedicine. 2021;90:153647. doi: 10.1016/j.phymed.2021.153647.
</cite> [<a href="https://doi.org/10.1016/j.phymed.2021.153647" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34362632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytomedicine&amp;title=Honokiol:%20A%20review%20of%20its%20pharmacological%20potential%20and%20therapeutic%20insights&amp;volume=90&amp;publication_year=2021&amp;pages=153647&amp;pmid=34362632&amp;doi=10.1016/j.phymed.2021.153647&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0162">
<span class="label">162.</span><cite>Chen Y-Q, Chen H-Y, Tang Q-Q, et al. 
Protective effect of quercetin on kidney diseases: from chemistry to herbal medicines. Front Pharmacol. 2022;13:968226. doi: 10.3389/fphar.2022.968226.
</cite> [<a href="https://doi.org/10.3389/fphar.2022.968226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9478191/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36120321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Protective%20effect%20of%20quercetin%20on%20kidney%20diseases:%20from%20chemistry%20to%20herbal%20medicines&amp;volume=13&amp;publication_year=2022&amp;pages=968226&amp;pmid=36120321&amp;doi=10.3389/fphar.2022.968226&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0163">
<span class="label">163.</span><cite>Quan Y, Park W, Jin J, et al. 
Sirtuin 3 activation by honokiol decreases unilateral ureteral obstruction-induced renal inflammation and fibrosis via regulation of mitochondrial dynamics and the renal NF-κB-TGF-β1/Smad signaling pathway. Int J Mol Sci. 2020;21(2):402. doi: 10.3390/ijms21020402.
</cite> [<a href="https://doi.org/10.3390/ijms21020402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7014106/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31936371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Sirtuin%203%20activation%20by%20honokiol%20decreases%20unilateral%20ureteral%20obstruction-induced%20renal%20inflammation%20and%20fibrosis%20via%20regulation%20of%20mitochondrial%20dynamics%20and%20the%20renal%20NF-%CE%BAB-TGF-%CE%B21/Smad%20signaling%20pathway&amp;volume=21&amp;issue=2&amp;publication_year=2020&amp;pages=402&amp;pmid=31936371&amp;doi=10.3390/ijms21020402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0164">
<span class="label">164.</span><cite>Ma Q, Xu M, Jing X, et al. 
Honokiol suppresses the aberrant interactions between renal resident macrophages and tubular epithelial cells in lupus nephritis through the NLRP3/IL-33/ST2 axis. Cell Death Dis. 2023;14(3):174. doi: 10.1038/s41419-023-05680-9.
</cite> [<a href="https://doi.org/10.1038/s41419-023-05680-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9977833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36859530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Honokiol%20suppresses%20the%20aberrant%20interactions%20between%20renal%20resident%20macrophages%20and%20tubular%20epithelial%20cells%20in%20lupus%20nephritis%20through%20the%20NLRP3/IL-33/ST2%20axis&amp;volume=14&amp;issue=3&amp;publication_year=2023&amp;pages=174&amp;pmid=36859530&amp;doi=10.1038/s41419-023-05680-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0165">
<span class="label">165.</span><cite>Remsberg CM, Yáñez JA, Ohgami Y, et al. 
Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res. 2008;22(2):169–179. doi: 10.1002/ptr.2277.
</cite> [<a href="https://doi.org/10.1002/ptr.2277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17726731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytother%20Res&amp;title=Pharmacometrics%20of%20pterostilbene:%20preclinical%20pharmacokinetics%20and%20metabolism,%20anticancer,%20antiinflammatory,%20antioxidant%20and%20analgesic%20activity&amp;volume=22&amp;issue=2&amp;publication_year=2008&amp;pages=169-179&amp;pmid=17726731&amp;doi=10.1002/ptr.2277&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0166">
<span class="label">166.</span><cite>Gu T-T, Chen T-Y, Yang Y-Z, et al. 
Pterostilbene alleviates fructose-induced renal fibrosis by suppressing TGF-β1/TGF-β type I receptor/Smads signaling in proximal tubular epithelial cells. Eur J Pharmacol. 2019;842:70–78. doi: 10.1016/j.ejphar.2018.10.008.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2018.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30336139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pharmacol&amp;title=Pterostilbene%20alleviates%20fructose-induced%20renal%20fibrosis%20by%20suppressing%20TGF-%CE%B21/TGF-%CE%B2%20type%20I%20receptor/Smads%20signaling%20in%20proximal%20tubular%20epithelial%20cells&amp;volume=842&amp;publication_year=2019&amp;pages=70-78&amp;pmid=30336139&amp;doi=10.1016/j.ejphar.2018.10.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0167">
<span class="label">167.</span><cite>Wang W, Li K, Bai D, et al. 
Pterostilbene: a potential therapeutic agent for fibrotic diseases. Inflammopharmacology. 2024;32(2):975–989. doi: 10.1007/s10787-024-01440-z.
</cite> [<a href="https://doi.org/10.1007/s10787-024-01440-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38429613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflammopharmacology&amp;title=Pterostilbene:%20a%20potential%20therapeutic%20agent%20for%20fibrotic%20diseases&amp;volume=32&amp;issue=2&amp;publication_year=2024&amp;pages=975-989&amp;pmid=38429613&amp;doi=10.1007/s10787-024-01440-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0168">
<span class="label">168.</span><cite>Wei W, Bu-Hui L, Yi-Gang W, et al. 
[Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose]. Zhongguo Zhong Yao Za Zhi. 2019;44(24):5457–5464. doi: 10.19540/j.cnki.cjcmm.20191114.401.</cite> [<a href="https://doi.org/10.19540/j.cnki.cjcmm.20191114.401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32237395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhongguo%20Zhong%20Yao%20Za%20Zhi&amp;title=%5BTriptolide%20inhibits%20NLRP3%20inflammasome%20activation%20and%20ameliorates%20podocyte%20epithelial-mesenchymal%20transition%20induced%20by%20high%20glucose%5D&amp;publication_year=2019&amp;pmid=32237395&amp;doi=10.19540/j.cnki.cjcmm.20191114.401&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0169">
<span class="label">169.</span><cite>Chenlei L, Tianyang C, Bingbing Z, et al. 
Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway. Renal Failure. 2023;45(1):2165103. doi: 10.1080/0886022X.2023.2165103.</cite> [<a href="https://doi.org/10.1080/0886022X.2023.2165103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10035962/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36938748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Renal%20Failure&amp;title=Triptolide%20protects%20against%20podocyte%20injury%20in%20diabetic%20nephropathy%20by%20activating%20the%20Nrf2/HO-1%20pathway%20and%20inhibiting%20the%20NLRP3%20inflammasome%20pathway&amp;publication_year=2023&amp;pmid=36938748&amp;doi=10.1080/0886022X.2023.2165103&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0170">
<span class="label">170.</span><cite>Ma CH, Kang LL, Ren HM, et al. 
Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in high fructose-fed rats. J Ethnopharmacol. 2015;172:108–117. doi: 10.1016/j.jep.2015.06.015.
</cite> [<a href="https://doi.org/10.1016/j.jep.2015.06.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26117533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Ethnopharmacol&amp;title=Simiao%20pill%20ameliorates%20renal%20glomerular%20injury%20via%20increasing%20Sirt1%20expression%20and%20suppressing%20NF-%CE%BAB/NLRP3%20inflammasome%20activation%20in%20high%20fructose-fed%20rats&amp;volume=172&amp;publication_year=2015&amp;pages=108-117&amp;pmid=26117533&amp;doi=10.1016/j.jep.2015.06.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0171">
<span class="label">171.</span><cite>Shui G, Cai Z, Wang F, et al. 
Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation. BMC Complement Med Ther. 2022;22(1):278. doi: 10.1186/s12906-022-03757-0.
</cite> [<a href="https://doi.org/10.1186/s12906-022-03757-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9587568/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36271349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Complement%20Med%20Ther&amp;title=Simiao%20pill%20inhibits%20epithelial%20mesenchymal%20transition%20in%20a%20mouse%20model%20of%20chronic%20hyperuricemic%20nephropathy%20by%20inhibiting%20NLRP3%20inflammasome%20activation&amp;volume=22&amp;issue=1&amp;publication_year=2022&amp;pages=278&amp;pmid=36271349&amp;doi=10.1186/s12906-022-03757-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0172">
<span class="label">172.</span><cite>Lu J-R, Han H-Y, Chen J, et al. 
Protective effects of bu-shen-huo-xue formula against 5/6 nephrectomy-induced chronic renal failure in rats. Evid Based Complement Alternat Med. 2014;2014:589846. doi: 10.1155/2014/589846.</cite> [<a href="https://doi.org/10.1155/2014/589846" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4020566/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24864155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Evid%20Based%20Complement%20Alternat%20Med&amp;title=Protective%20effects%20of%20bu-shen-huo-xue%20formula%20against%205/6%20nephrectomy-induced%20chronic%20renal%20failure%20in%20rats&amp;volume=2014&amp;publication_year=2014&amp;pmid=24864155&amp;doi=10.1155/2014/589846&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0174">
<span class="label">174.</span><cite>Østergaard JA, Jha JC, Sharma A, et al. 
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease. Clin Sci (Lond). 2022;136(2):167–180. doi: 10.1042/CS20210865.
</cite> [<a href="https://doi.org/10.1042/CS20210865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8777085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35048962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Sci%20(Lond)&amp;title=Adverse%20renal%20effects%20of%20NLRP3%20inflammasome%20inhibition%20by%20MCC950%20in%20an%20interventional%20model%20of%20diabetic%20kidney%20disease&amp;volume=136&amp;issue=2&amp;publication_year=2022&amp;pages=167-180&amp;pmid=35048962&amp;doi=10.1042/CS20210865&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0175">
<span class="label">175.</span><cite>Hsu Y-H, Zheng C-M, Chou C-L, et al. 
Therapeutic effect of endothelin-converting enzyme inhibitor on chronic kidney disease through the inhibition of endoplasmic reticulum stress and the NLRP3 inflammasome. Biomedicines. 2021;9(4):398. doi: 10.3390/biomedicines9040398.
</cite> [<a href="https://doi.org/10.3390/biomedicines9040398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8067871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33917140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Therapeutic%20effect%20of%20endothelin-converting%20enzyme%20inhibitor%20on%20chronic%20kidney%20disease%20through%20the%20inhibition%20of%20endoplasmic%20reticulum%20stress%20and%20the%20NLRP3%20inflammasome&amp;volume=9&amp;issue=4&amp;publication_year=2021&amp;pages=398&amp;pmid=33917140&amp;doi=10.3390/biomedicines9040398&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Renal Failure are provided here courtesy of <strong>Taylor & Francis</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1080/0886022X.2025.2538798"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/IRNF_47_2538798.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372509/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372509/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372509%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372509/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372509/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372509/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841164/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372509/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841164/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372509/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372509/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="1IxwoUmsR1a10MPJrlujM8f3joGUgnfHWqkqcTKKTrrfWJ6TpPYCG4fICTqTIiqt">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
